var title_f38_62_39904="Conjugated equine estrogens: Patient drug information";
var content_f38_62_39904=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Conjugated equine estrogens: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/17/41238?source=see_link\">",
"       Conjugated equine estrogens (systemic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/48/17158?source=see_link\">",
"       Conjugated equine estrogens (topical): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11730 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-41.78.124.10-9FDBE1AB85-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39904=[""].join("\n");
var outline_f38_62_39904=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/17/41238?source=related_link\">",
"      Conjugated equine estrogens (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/48/17158?source=related_link\">",
"      Conjugated equine estrogens (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_62_39905="Dermatitis herpetiformis";
var content_f38_62_39905=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F70783&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F70783&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Dermatitis herpetiformis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Herpetiform clusters of vesicles on an erythematous, edamatous base with crusts and postinflammatory pigmentation on the upper back and shoulder.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Skin signs of immune, autoimmune, and rheumatic diseases. In: Color Atlas and Synopsis of Clinical Dermatology, 3rd ed, Fitzpatrick TB, Johnson RA, Wolff K (Eds), McGraw-Hill, New York 1997. p.327. Copyright &copy; 1997 McGraw Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39905=[""].join("\n");
var outline_f38_62_39905=null;
var title_f38_62_39906="Open fx forearm";
var content_f38_62_39906=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Open forearm fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 453px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Open fracture. This 8-year-old boy fell on his hand and was referred to the emergency department with a deformed forearm (Panel A) due to a distal radial/ulnar fracture. After removal from his splint a small ecchymosis and laceration were noted over the ventral aspect of his forearm (Panel B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baskin M. Trauma: Extremeties. In: Atlas of Pediatric Emergency Medicine, Fleisher GR, Ludwig S, Baskin M (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39906=[""].join("\n");
var outline_f38_62_39906=null;
var title_f38_62_39907="Tolnaftate: Patient drug information";
var content_f38_62_39907=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tolnaftate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/61/28627?source=see_link\">",
"     see \"Tolnaftate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/51/43826?source=see_link\">",
"     see \"Tolnaftate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F229126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Blis-To-Sol&reg; [OTC];",
"     </li>",
"     <li>",
"      Mycocide&reg; NS [OTC];",
"     </li>",
"     <li>",
"      Podactin Powder [OTC];",
"     </li>",
"     <li>",
"      Tinactin&reg; Antifungal Deodorant [OTC];",
"     </li>",
"     <li>",
"      Tinactin&reg; Antifungal Jock Itch [OTC];",
"     </li>",
"     <li>",
"      Tinactin&reg; Antifungal [OTC];",
"     </li>",
"     <li>",
"      Tinaderm [OTC];",
"     </li>",
"     <li>",
"      Ting&reg; Cream [OTC];",
"     </li>",
"     <li>",
"      Ting&reg; Spray Liquid [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F229127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pitrex",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012496\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tolnaftate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have nail or scalp infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012501\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012503\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10012499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012504\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11104 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-BD1901CB76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39907=[""].join("\n");
var outline_f38_62_39907=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229126\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229127\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012496\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012495\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012500\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012501\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012503\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012498\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012499\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012504\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012505\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?27/61/28627?source=related_link\">",
"      Tolnaftate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?42/51/43826?source=related_link\">",
"      Tolnaftate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_62_39908="Timing of late preterm or early term birth";
var content_f38_62_39908=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52580&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Timing of late preterm or early term birth: Balancing the risks of pregnancy continuation and delivery before term",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Conceptual diagram representing the competing risks and benefits of indicated late-preterm or early-term birth compared with pregnancy continuation. The figure does not represent specific magnitudes or rates of changes in risks because these will vary according to the specific pregnancy complication and individual circumstances. Neonatal morbidity and mortality decreases with advancing gestation; these typically are related to prematurity. For these deliveries in the late-preterm or early-term period, maternal morbidity and mortality generally are higher as a result of prolonged or failed induction and resultant cesarean deliveries. Potential maternal consequences of continued pregnancy in the setting of complicated conditions and maternal morbidity and mortality are related to hemorrhage, hypertensive crises, and uterine rupture. Continued pregnancy in these settings also can result in fetal morbidity and stillbirth due to uteroplacental insufficiency.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Spong CY, Mercer BM, D'Alton M, et al. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011; 118:323. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39908=[""].join("\n");
var outline_f38_62_39908=null;
var title_f38_62_39909="Ovarian hyperthecosis Light";
var content_f38_62_39909=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F75548&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F75548&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ovarian hyperthecosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 258px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph from a woman with ovarian hyperthecosis shows nests of steroidogenically active luteinized theca cells in the ovarian stroma. These cells, which are large and lighter looking (arrows) are derived from differentiation of the ovarian interstitial cells. Hematoxylin and eosin x 400.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Manubai Nagamani, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39909=[""].join("\n");
var outline_f38_62_39909=null;
var title_f38_62_39910="Clinical manifestations and diagnosis of pulmonic stenosis";
var content_f38_62_39910=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of pulmonic stenosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/62/39910/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/62/39910/contributors\">",
"     Karen Stout, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/62/39910/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/62/39910/contributors\">",
"     Heidi M Connolly, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/62/39910/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/62/39910/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/62/39910/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 20, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenosis of the pulmonary valve is a relatively common congenital defect, occurring in approximately 10 percent of children with congenital heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/1\">",
"     1",
"    </a>",
"    ]. There is a slight female predominance, and familial occurrence has been reported in 2 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonic stenosis in children is usually associated with a benign clinical course, and excellent treatment options are available for severe cases. Thus, there is a high rate of survival into adulthood. This topic will review the pathophysiology, clinical manifestations, and diagnosis of pulmonic stenosis. The natural history and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=see_link\">",
"     \"Natural history and treatment of pulmonic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonic stenosis can occur at three locations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Valvular",
"     </li>",
"     <li>",
"      Subvalvular",
"     </li>",
"     <li>",
"      Supravalvular",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Valvular pulmonic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trileaflet valve is present in patients with typical valvular pulmonic stenosis, with varying degrees of fibrous thickening and fusion of the commissures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/3\">",
"     3",
"    </a>",
"    ]. The restricted leaflets typically have a conical or dome-shaped appearance during systole, with an orifice in a shape similar to a \"fish-mouth\". Calcification of the stenotic valve is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/4\">",
"     4",
"    </a>",
"    ]. Bicuspid pulmonic valves have been described but occur in less than 20 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition to pulmonary stenosis, there may be pulmonary artery dilation as a consequence of underlying connective tissue abnormality and eccentric flow due to the stenotic valve. If pulmonic valve stenosis is sufficiently severe, right ventricular hypertrophy may occur over time. Right ventricular chamber enlargement is not expected in patients with pulmonic stenosis unless there is associated pulmonary regurgitation.",
"   </p>",
"   <p>",
"    A small proportion of patients (particularly those with Noonan syndrome) have a markedly dysplastic valve, with prominent leaflet thickening, little commissural fusion, and often a hypoplastic annulus and proximal pulmonary artery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. These valves are often severely stenotic and usually require intervention during childhood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8680319\">",
"    <span class=\"h3\">",
"     Associated conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Valvular pulmonic stenosis is most commonly an isolated lesion. In a minority of cases it is associated with other conditions including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tetralogy of Fallot. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13752?source=see_link\">",
"       \"Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital rubella syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/49/10010?source=see_link&amp;anchor=H8#H8\">",
"       \"Congenital rubella syndrome: Clinical features and diagnosis\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Noonan syndrome. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=see_link&amp;anchor=H19#H19\">",
"       \"Causes of short stature\", section on 'Noonan syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acquired pulmonic stenosis is most often due to carcinoid syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12472?source=see_link\">",
"       \"Carcinoid heart disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Subvalvular pulmonic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary fibromuscular narrowing limited to the right ventricular outflow tract is an extremely rare phenomenon that is probably part of the spectrum of illness associated with a double-chambered right ventricle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/10\">",
"     10",
"    </a>",
"    ]. In comparison, varying degrees of secondary outflow tract narrowing are commonly seen as part of the overall muscular hypertrophy of the right ventricle induced by pulmonic stenosis. This secondary obstruction often regresses following valvotomy or valvuloplasty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=see_link\">",
"     \"Natural history and treatment of pulmonic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Right ventricular outflow tract obstruction is one of the cardinal features of tetralogy of Fallot. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13752?source=see_link\">",
"     \"Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Supravalvular pulmonic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated or multiple areas of narrowing of the main pulmonary artery or branches may occur. It is rare as a de novo finding in adults but can be seen in children either as part of another congenital defect or as an isolated abnormality. Right ventricular pressure overload is seen at catheterization, and angiography usually demonstrates multiple focal or diffuse areas of stenosis. When isolated, it occurs most often at the left pulmonary artery takeoff, presumably due to changes related to the insertion of the ductus arteriosus. Balloon pulmonary angioplasty may offer these patients successful short-term reduction in right ventricular hypertension and alleviation of symptoms.",
"   </p>",
"   <p>",
"    Pulmonary arterial stenosis often occurs in association with other cardiac or noncardiac congenital defects. These include tetralogy of Fallot and the congenital rubella syndrome as well as rarer disorders such as Williams syndrome, Noonan syndrome, Alagille syndrome, and LEOPARD syndrome. Branch pulmonary stenosis are a potential sequelae of prior Blalock-Taussig shunts and both main and branch pulmonary stenosis may result from the arterial switch repair of transposition of the great arteries. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/59/36793?source=see_link\">",
"     \"Management and outcome of D-transposition of the great arteries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Survival into adulthood is common in patients with pulmonic stenosis, even in the absence of surgical correction or valvotomy. However, fibrous thickening and occasionally calcification of the valve with age may result in decreased valve mobility and increased obstruction. Thus, the patient who is initially asymptomatic may begin to experience symptoms that vary from mild exertional dyspnea to signs and symptoms of right heart failure, depending upon the severity of obstruction and the degree of myocardial compensation. Moderate to severe obstruction may lead to an inability to augment pulmonary blood flow during exertion, resulting in exercise-induced fatigue, syncope, or chest pain. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=see_link\">",
"     \"Natural history and treatment of pulmonic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Physical findings are related to severity of stenosis, thus the findings in adults with pulmonic stenosis are often subtle, since most patients have mild to moderate disease. The typical constellation includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prominence of the jugular venous \"A\" wave, although overall jugular venous pressure is usually normal. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/59/33719?source=see_link\">",
"       \"Examination of the jugular venous pulse\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Prominent right ventricular systolic impulse with a left para-sternal lift.",
"     </li>",
"     <li>",
"      A systolic ejection murmur with maximal intensity at the left upper sternal border. The murmur duration increases with increasing degrees of stenosis at valve level, and its peak intensity occurs later in systole. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26202?source=see_link\">",
"       \"Auscultation of cardiac murmurs\"",
"      </a>",
"      .) In patients with milder stenosis, the murmur will vary with respiration. The murmur radiates to the back.",
"     </li>",
"     <li>",
"      A pulmonary ejection sound (or click). Presence of this high frequency component usually denotes a mild or moderate degree of stenosis, since it occurs earlier in systole with severe stenosis, and eventually becomes \"buried\" in the first heart sound [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/12\">",
"       12",
"      </a>",
"      ]. The ejection click decreases in intensity with inspiration. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/56/22410?source=see_link\">",
"       \"Auscultation of heart sounds\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Splitting of the second heart sound results from prolonged ejection and delay in the pulmonic component. The degree of splitting increases with more severe stenosis, and may become fixed in the most severe forms due to a fixed right ventricular output or development of conduction delay. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/56/22410?source=see_link\">",
"       \"Auscultation of heart sounds\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A right-sided fourth heart sound may be heard over the left sternal border in cases of right ventricular hypertrophy and diminished compliance.",
"     </li>",
"     <li>",
"      Varying degrees of tricuspid regurgitation may be detected. Pulmonic regurgitation may also be detected as a decrescendo, diastolic murmur; this finding is more prevalent following valvotomy or valvuloplasty [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26202?source=see_link\">",
"       \"Auscultation of cardiac murmurs\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cyanosis occurs only in the most severe cases, and is indicative of right to left shunting at the atrial level through a septal defect or patent foramen ovale.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic tests used in the evaluation for pulmonic stenosis include the electrocardiogram, echocardiography, cardiovascular magnetic resonance, and cardiac catheterization. The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on the management of patients with valvular heart disease included recommendations for the initial evaluation and follow-up of patients with pulmonic stenosis (",
"    <a class=\"graphic graphic_table graphicRef80870 \" href=\"mobipreview.htm?26/2/26667\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;The baseline electrocardiogram is often normal, particularly in cases of mild or moderate pulmonic stenosis. In more severe cases, the mean frontal axis may deviate to the right and varying degrees of right ventricular hypertrophy may be detected. Right bundle branch block is also seen,",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two- and three-dimensional echocardiography are excellent modalities for assessment of pulmonary valvular anatomy, localization of the stenosis, and evaluation of right ventricular size and function. The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines concluded that echocardiography is the preferred test for evaluating the severity of pulmonic stenosis (",
"    <a class=\"graphic graphic_table graphicRef80870 \" href=\"mobipreview.htm?26/2/26667\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20567?source=see_link\">",
"     \"Echocardiographic evaluation of the pulmonic valve and pulmonary artery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Typical valvular stenosis is characterized by mildly thickened leaflets with restricted systolic excursion, leading to a domed appearance [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Presystolic doming of the valve may be seen during atrial contraction in patients with more severe stenosis who have a noncompliant right ventricle [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/15\">",
"       15",
"      </a>",
"      ]; doming correlates with the progressive decrease in the systolic ejection click [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Truly dysplastic valves are characterized by markedly thickened and seemingly immobile leaflets, hypoplasia of the valve annulus, and often supra-annular narrowing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/16\">",
"       16",
"      </a>",
"      ]. The ability to identify dysplastic valves is essential since balloon valvuloplasty in these patients may achieve less than optimal results. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=see_link&amp;anchor=H11#H11\">",
"       \"Natural history and treatment of pulmonic stenosis\", section on 'Balloon valvotomy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Echocardiographic detection of pulmonic valve calcification is rare [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Continuous wave Doppler measurement of peak systolic velocities provides estimates of the transpulmonic gradient that are correlated closely with simultaneous values obtained at cardiac catheterization (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57322 \" href=\"mobipreview.htm?12/14/12527\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Color Doppler is particularly useful for the detection and quantification of pulmonic regurgitation, using measurement of the jet length and planimetered jet area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/20\">",
"     20",
"    </a>",
"    ]. This technique is of particular importance in the assessment of residual insufficiency in patients who have undergone balloon valvuloplasty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/11,21\">",
"     11,21",
"    </a>",
"    ]. Color Doppler is also useful for identification of the location of obstruction. Flow acceleration proximal to valve level suggests subvalvar pulmonic stenosis.",
"   </p>",
"   <p>",
"    Transesophageal echocardiography is",
"    <strong>",
"     NOT",
"    </strong>",
"    indicated in the routine evaluation of pulmonic stenosis. However, it may be helpful if the diagnosis of pulmonic valve endocarditis is suspected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/22\">",
"     22",
"    </a>",
"    ], though the localization of the pulmonary valve relatively far from the TEE probe may make visualization of the pulmonary valve difficult.",
"   </p>",
"   <p>",
"    Classification of the severity of pulmonic stenosis and relationship to prognosis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=see_link&amp;anchor=H9858791#H9858791\">",
"     \"Natural history and treatment of pulmonic stenosis\", section on 'Grading severity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cardiac catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic cardiac catheterization is rarely required in patients with pulmonic stenosis due to the extensive characterization of valvular structure, severity of stenosis, and right ventricular size and function derived from echocardiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/23\">",
"     23",
"    </a>",
"    ]. Invasive hemodynamic measurements and ventriculography may be useful when the severity of stenosis is unclear or a significant secondary infundibular stenosis is suspected in addition to the valvular stenosis.",
"   </p>",
"   <p>",
"    Cardiac catheterization is primarily performed in patients who are candidates for balloon valvotomy for confirmation of gradients meriting intervention immediately prior to the procedure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=see_link&amp;anchor=H11#H11\">",
"     \"Natural history and treatment of pulmonic stenosis\", section on 'Balloon valvotomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ADDITIONAL CLINICAL CONCERNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several clinical concerns are shared equally among those with varying severity of pulmonic stenosis, regardless of the type of treatment given (medical or surgical).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Infective endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of infective endocarditis in patients with pulmonic stenosis followed to adulthood is very low compared to other types of valvular heart disease (0.9 per 10,000 person-years versus 27.1 for those with aortic stenosis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/24\">",
"     24",
"    </a>",
"    ]. Nevertheless, the risk is a little more than twice that in the general population (0.38 per 10,000 person-years).",
"   </p>",
"   <p>",
"    In addition, there are currently no data regarding the efficacy of antibiotic prophylaxis in patients with pulmonic stenosis because of the relatively low incidence of endocarditis. Furthermore, the risk of anaphylactic reactions to antibiotic prophylaxis may be as common as the incidence of endocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2007 American Heart Association guidelines on the prevention of bacterial endocarditis recommended that only patients with the highest risk of the development of endocarditis receive antimicrobial prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/25\">",
"     25",
"    </a>",
"    ]. Most patients with valvular heart disease, including those with pulmonic stenosis, are not included in this group unless they have had prior endocarditis or have a prosthetic valve.(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Arrhythmia",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is an increased incidence of arrhythmia in patients with pulmonic stenosis; these include supraventricular premature beats, ventricular premature beats, and ventricular couplets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39910/abstract/26\">",
"     26",
"    </a>",
"    ]. Arrhythmias are seen in patients managed either medically or with valvotomy or valvuloplasty. Only those with symptomatic palpitations require evaluation. Electrophysiologic testing is generally not necessary, since the incidence of malignant arrhythmias is low.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8679925\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stenosis of the pulmonary valve is a relatively common congenital defect, occurring in approximately 10 percent of children with congenital heart disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A trileaflet valve is present in patients with typical valvular pulmonic stenosis, with varying degrees of fibrous thickening and fusion of the commissures. A small proportion of patients (particularly those with Noonan syndrome) have a markedly dysplastic valve associated with severe stenosis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Valvular pulmonic stenosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary fibromuscular narrowing limited to the right ventricular outflow tract is an extremely rare phenomenon that is probably part of the spectrum of illness associated with a double-chambered right ventricle. In contrast, secondary outflow tract narrowing is commonly seen as part of the hypertrophy of the right ventricle induced by pulmonic stenosis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Subvalvular pulmonic stenosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulmonary arterial stenosis often occurs in association with other cardiac or noncardiac congenital defects. These include tetralogy of Fallot and the congenital rubella syndrome as well as rarer disorders such as Williams syndrome, Noonan syndrome, Alagille syndrome, and LEOPARD syndrome. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Supravalvular pulmonic stenosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms of pulmonic stenosis with severe obstruction include exertional dyspnea, fatigue, syncope, and chest pain. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The systolic ejection murmur of pulmonic stenosis becomes later peaking and louder as the stenosis worsens, assuming preserved right ventricular function. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of pulmonic stenosis is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=see_link\">",
"       \"Natural history and treatment of pulmonic stenosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1801228\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The UpToDate editorial staff would&nbsp;like to thank Drs. Martin G. Keane and Martin G. St. John Sutton for their contributions as Authors and Dr. Catherine M. Otto for her contributions as a Section Editor to previous versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rocchini AP, Emmanouilides GC. Moss and Adams Heart Disease in Infants, Children, and Adolescents, 5th ed, Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP (Eds), Williams &amp; Wilkins, Baltimore 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/2\">",
"      CAMPBELL M. Factors in the aetiology of pulmonary stenosis. Br Heart J 1962; 24:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/3\">",
"      Snellen HA, Hartman H, Buis-Liem TN, et al. Pulmonic stenosis. Circulation 1968; 38:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/4\">",
"      Gabriele OF, Scatliff JH. Pulmonary valve calcification. Am Heart J 1970; 80:299.",
"     </a>",
"    </li>",
"    <li>",
"     Keith JD, Rowe RD, Vlad P. Heart Disease in Infancy and Childhood, 3rd ed, MacMillan, New York 1978.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/6\">",
"      Koretzky ED, Moller JH, Korns ME, et al. Congenital pulmonary stenosis resulting from dysplasia of valve. Circulation 1969; 40:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/7\">",
"      Linde LM, Turner SW, Sparkes RS. Pulmonary valvular dysplasia. A cardiofacial syndrome. Br Heart J 1973; 35:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/8\">",
"      Rowe RD. Cardiovascular disease in the rubella syndrome. Cardiovasc Clin 1973; 5:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/9\">",
"      Simula DV, Edwards WD, Tazelaar HD, et al. Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc 2002; 77:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/10\">",
"      Cabrera A, Martinez P, Rumoroso JR, et al. Double-chambered right ventricle. Eur Heart J 1995; 16:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/11\">",
"      Robertson M, Benson LN, Smallhorn JS, et al. The morphology of the right ventricular outflow tract after percutaneous pulmonary valvotomy: long term follow up. Br Heart J 1987; 58:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/12\">",
"      Hultgren HN, Reeve R, Cohn K, McLeod R. The ejection click of valvular pulmonic stenosis. Circulation 1969; 40:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/13\">",
"      Hayes CJ, Gersony WM, Driscoll DJ, et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation 1993; 87:I28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/14\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/15\">",
"      Weyman AE, Hurwitz RA, Girod DA, et al. Cross-sectional echocardiographic visualization of the stenotic pulmonary valve. Circulation 1977; 56:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/16\">",
"      Musewe NN, Robertson MA, Benson LN, et al. The dysplastic pulmonary valve: echocardiographic features and results of balloon dilatation. Br Heart J 1987; 57:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/17\">",
"      Pieroni DR, Nishimura RA, Bierman FZ, et al. Second natural history study of congenital heart defects. Ventricular septal defect: echocardiography. Circulation 1993; 87:I80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/18\">",
"      Lima CO, Sahn DJ, Valdes-Cruz LM, et al. Noninvasive prediction of transvalvular pressure gradient in patients with pulmonary stenosis by quantitative two-dimensional echocardiographic Doppler studies. Circulation 1983; 67:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/19\">",
"      Johnson GL, Kwan OL, Handshoe S, et al. Accuracy of combined two-dimensional echocardiography and continuous wave Doppler recordings in the estimation of pressure gradient in right ventricular outlet obstruction. J Am Coll Cardiol 1984; 3:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/20\">",
"      Takao S, Miyatake K, Izumi S, et al. Clinical implications of pulmonary regurgitation in healthy individuals: detection by cross sectional pulsed Doppler echocardiography. Br Heart J 1988; 59:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/21\">",
"      Rocchini AP, Beekman RH. Balloon angioplasty in the treatment of pulmonary valve stenosis and coarctation of the aorta. Tex Heart Inst J 1986; 13:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/22\">",
"      Shapiro SM, Young E, Ginzton LE, Bayer AS. Pulmonic valve endocarditis as an underdiagnosed disease: role of transesophageal echocardiography. J Am Soc Echocardiogr 1992; 5:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/23\">",
"      Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008; 118:2395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/24\">",
"      Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993; 87:I121.",
"     </a>",
"    </li>",
"    <li>",
"     Wilson W, Taubert KA, Gewitz M, et al. Prevention of Infective Endocarditis. Guidelines From the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 115 published online April 19, 2007. www.circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.106.183095v1 (Accessed on May 04, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39910/abstract/26\">",
"      Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24-hour ECG monitoring. Circulation 1993; 87:I89.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8120 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-8BB6C55152-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39910=[""].join("\n");
var outline_f38_62_39910=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8679925\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Valvular pulmonic stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8680319\">",
"      - Associated conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Subvalvular pulmonic stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Supravalvular pulmonic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ADDITIONAL CLINICAL CONCERNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8679925\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1801228\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8120\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8120|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?12/14/12527\" title=\"diagnostic image 1\">",
"      Pulmonic stenosis Doppler II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8120|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/2/26667\" title=\"table 1\">",
"      Evaluation pulmonic stenosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12472?source=related_link\">",
"      Carcinoid heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=related_link\">",
"      Causes of short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/49/10010?source=related_link\">",
"      Congenital rubella syndrome: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20567?source=related_link\">",
"      Echocardiographic evaluation of the pulmonic valve and pulmonary artery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/59/33719?source=related_link\">",
"      Examination of the jugular venous pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/59/36793?source=related_link\">",
"      Management and outcome of D-transposition of the great arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=related_link\">",
"      Natural history and treatment of pulmonic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13752?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_62_39911="Apixaban: Drug information";
var content_f38_62_39911=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Apixaban: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/40/34436?source=see_link\">",
"    see \"Apixaban: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F15868354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F15881499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Eliquis&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14471661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Eliquis&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F14478981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Factor Xa Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F14479016\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Nonvalvular atrial fibrillation (to prevent stroke and systemic embolism):",
"     </b>",
"     Oral: 5 mg twice daily",
"     <b>",
"      unless",
"     </b>",
"     patient has any 2 of the following: Age &ge;80 years, body weight &le;60 kg, or serum creatinine &ge;1.5 mg/dL, then reduce dose to 2.5 mg twice daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Per the American Heart Association, the following apixaban doses have been recommended based on the following criteria (Furie, 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Patients with &ge;1 additional risk factor for stroke and &le;",
"     <b>",
"      1",
"     </b>",
"     of the following: Age &ge;80 years, weight &le;60 kg, or serum creatinine &ge;1.5 mg/dL (also see Dosing: Renal Impairment): Alternative to aspirin or warfarin depending on suitability of vitamin K antagonist (VKA) therapy: 5 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Patients with &ge;1 additional risk factor for stroke and &ge;",
"     <b>",
"      2",
"     </b>",
"     of the following: Age &ge;80 years, weight &le;60 kg, or serum creatinine &ge;1.5 mg/dL (also see Dosing: Renal Impairment): Alternative to aspirin or warfarin depending on suitability of vitamin K antagonist (VKA) therapy: 2.5 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Conversion from warfarin to apixaban:",
"     </i>",
"     Discontinue warfarin and initiate apixaban when INR is &lt;2.0",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Conversion from apixaban to warfarin:",
"     </i>",
"     Apixaban affects the",
"     <b>",
"      INR",
"     </b>",
"     ; measuring the INR during coadministration with warfarin therapy may not be useful for determining an appropriate dose of warfarin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     U.S. labeling: If continuous anticoagulation is necessary, discontinue apixaban and begin both a parenteral anticoagulant with warfarin when the next dose of apixaban is due; discontinue parenteral anticoagulant when INR reaches an acceptable range.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Canadian labeling: Initiate warfarin or other vitamin K antagonist  (VKA) at usual starting doses and continue apixaban until INR &ge;2, then discontinue apixaban. During concomitant therapy, manufacturer recommends initiating INR testing on day 3 and just prior to each dose of apixaban.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Conversion between apixaban and other non-warfarin anticoagulants:",
"     </i>",
"     Discontinue anticoagulant being taken and begin the other at the next scheduled dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Postoperative venous thromboprophylaxis:",
"     </b>",
"     Canadian labeling (not in U.S. labeling): Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hip replacement surgery: 2.5 mg twice daily beginning 12-24 hours postoperatively and after achievement of hemostasis; duration: 32-38 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Knee replacement surgery: 2.5 mg twice daily beginning 12-24 hours postoperatively and after achievement of hemostasis; duration: 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Venous thromboembolism (DVT or PE), extended treatment (unlabeled use):",
"     </b>",
"     Oral: 2.5 mg twice daily.",
"     <b>",
"      Note:",
"     </b>",
"     Patients in the clinical trial completed 6-12 months of standard anticoagulant therapy and uncertainty existed about whether or not to continue anticoagulation. Patients were also randomized to a 5 mg twice daily dosage; however, slightly more non-major bleeding occurred (Agnelli, 2013).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      <i>",
"       Dosage adjustment of apixaban with concomitant medications:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     U.S. labeling: Dual strong CYP3A4 and P-glycoprotein inhibitors (eg, clarithromycin, ketoconazole, itraconazole, ritonavir): 2.5 mg twice daily;",
"     <b>",
"      Note:",
"     </b>",
"     Avoid concomitant use if patient is already taking apixaban 2.5 mg twice daily or patient meets 2 of the following criteria: Age &ge;80 years, body weight &le;60 kg, or serum creatinine &ge;1.5 mg/dL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Canadian labeling:  Dual CYP3A4 and P-glycoprotein inhibitors: No dosage adjustment necessary for moderate inhibitors. Use is contraindicated with strong inhibitors.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F14479017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Refer to adult dosing. Nonvalvular atrial fibrillation (to prevent stroke and systemic embolism): If patient is &ge;80 years of age",
"     <b>",
"      and",
"     </b>",
"     <i>",
"      either",
"     </i>",
"     weighs &le;60 kg or has a serum creatinine &ge;1.5 mg/dL, then reduce dose to 2.5 mg twice daily.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F14479013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     U.S. labeling: Nonvalvular atrial fibrillation (to prevent stroke and systemic embolism):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Serum creatinine &ge;1.5 mg/dL",
"     <b>",
"      and",
"     </b>",
"     <i>",
"      either",
"     </i>",
"     age &ge;80 years or body weight &le;60 kg: 2.5 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute: No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied).",
"     <b>",
"      Note:",
"     </b>",
"     When used to prevent stroke with nonvalvular atrial fibrillation and Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;25 mL/minute, the American Heart Association/American Stroke Association recommends to avoid use (Furie, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Canadian labeling:",
"     <b>",
"      Note:",
"     </b>",
"     Estimated creatinine clearance (eCl",
"     <sub>",
"      cr",
"     </sub>",
"     ) may be calculated using Cockcroft-Gault equation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Nonvalvular atrial fibrillation (to prevent stroke and systemic embolism):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     eCl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;25 mL/minute: No dosage adjustment necessary. Patients with serum creatinine &ge;1.5 mg/dL and either age &ge;80 years or body weight &le;60 kg: 2.5 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     eCl",
"     <sub>",
"      cr",
"     </sub>",
"     15-24 mL/minute: No dosage adjustment provided in manufacturer&rsquo;s labeling (very limited data).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     eCl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute: Use is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     Dialysis: Use is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Postoperative venous thromboprophylaxis:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     eCl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 mL/minute): No dosage adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     eCl",
"     <sub>",
"      cr",
"     </sub>",
"     15 -29 mL/minute:  No dosage adjustment provided in manufacturer&rsquo;s labeling; use with caution as bleeding risk may be increased.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     eCl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute: Use is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     Dialysis: Use is not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F14479014\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     U.S. labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Mild impairment (Child-Pugh class A): No dosage adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Moderate impairment (Child-Pugh class B): No dosage adjustment provided in manufacturer&rsquo;s labeling; limited clinical experience.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Severe impairment (Child-Pugh class C): Use is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Canadian labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Mild or moderate impairment (Child-Pugh class A or B): No dosage adjustment required; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Severe impairment (Child-Pugh class C): Use is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Use is contraindicated in patients with hepatic disease associated with coagulopathy and clinically-relevant bleeding risk.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F15869945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Eliquis&reg;: 2.5 mg, 5 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F15881025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F15869944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM333961.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM333961.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F14479020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered without regard to meals. After hip/knee replacement (Canadian labeling), initial dose should be administered 12-24 hours postoperatively.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F14478984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     U.S. labeling: To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Canadian labeling: Postoperative prophylaxis of venous thromboembolism (VTE) following elective knee or hip replacement surgery; to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F14972349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     To reduce the risk of recurrent DVT and/or PE (in patients completing 6-12 months of standard anticoagulation for venous thromboembolism)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F14478979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F14478993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Includes adverse reactions from nonvalvular atrial fibrillation and hip/knee replacement surgery clinical trials.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%: Hematologic: Bleeding (5% to 12%; major: &le;2%; clinically-relevant non-major bleeding: 2% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Bruising (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Anemia (3%), postprocedural hemorrhage (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: GGT increased (1%), transaminases increased (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Alkaline phosphatase increased, allergic edema, anaphylaxis, bilirubin increased, epistaxis, GI hemorrhage, gingival bleeding, hematemesis, hematochezia, hematuria, hemoptysis, hypersensitivity, hypotension, incision site hematoma, incision site hemorrhage, intracranial hemorrhage, intraocular hemorrhage, melena, muscle hemorrhage, rash, rectal hemorrhage, syncope, thrombocytopenia, wound secretion",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F14478988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Severe hypersensitivity reaction (ie, anaphylaxis) to apixaban or any component of the formulation; active pathological bleeding",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Hypersensitivity to apixaban or any component of the formulation; clinically-significant active bleeding (including gastrointestinal bleeding); lesions or conditions at increased risk of clinically-significant bleeding (eg, cerebral infarct [ischemic or hemorrhagic], active peptic ulcer disease with recent bleeding; patients with spontaneous or acquired impairment of hemostasis); hepatic disease associated with coagulopathy and clinically-relevant bleeding risk; concomitant systemic treatment with agents that are strong inhibitors of both CYP3A4 and P-glycoprotein (P-gp); concomitant treatment with any other anticoagulant including unfractionated heparin (except at doses used to maintain patency of central venous or arterial catheter), low molecular weight heparins, heparin derivatives (eg, fondaparinux), and oral anticoagulants including warfarin, dabigatran, rivaroxaban except when transitioning to or from apixaban therapy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F14478989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Bleeding: Certain patients are at increased risk of bleeding; risk factors include bacterial endocarditis, congenital or acquired bleeding disorders, active GI ulcer, vascular retinopathy, thrombocytopenia, recent puncture of large vessels or organ biopsy, prior hemorrhagic stroke, intracerebral surgery, or other neuraxial procedure, severe uncontrolled hypertension, severe renal impairment, recent major surgery, recent major bleeding (intracranial, GI, intraocular, or pulmonary), concomitant use of drugs that affect hemostasis. Monitor for signs and symptoms of bleeding (weakness, dizziness, unexplained edema). Discontinue therapy with severe hemorrhage and promptly evaluate for bleeding source. No specific antidote exists for apixaban reversal; apixaban is not dialyzable. Although not evaluated in clinical trials, in the event of apixaban-related hemorrhage, the use of prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa may be considered. The use of activated oral charcoal may be considered if ingestion occurred within 2-6 hours of presentation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Thromboembolic events:",
"     <b>",
"      [U.S. Boxed Warning]: When used to prevent stroke in patients with nonvalvular atrial fibrillation, an increased risk of stroke may occur upon apixaban discontinuation if patient is not adequately anticoagulated with an alternative anticoagulant.",
"     </b>",
"     If apixaban must be discontinued for reasons other than bleeding, consider the use of another anticoagulant to prevent stroke from occurring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Acute coronary syndrome (ACS): In a clinical trial evaluating the use of apixaban in addition to standard antiplatelet therapy to reduce the risk of recurrent ischemic events post-ACS, an increased incidence of major bleeding (including intracranial and fatal bleeding) without any significant clinical benefit was observed (Alexander, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatic impairment: Avoid use in severe hepatic impairment (Child-Pugh class C); use with caution in mild or moderate impairment (Child-Pugh class A or B) as there is limited data in these patients. Patients with ALT/AST &gt;2 times ULN or total bilirubin &ge;1.5 times ULN and undergoing major orthopedic surgery (approved use in Canada; not an approved use in U.S.) were excluded from clinical trials; use with caution in these patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Systemic exposure increases with worsening renal function. Bleeding risk may be increased in severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15-29 mL/minute); use with caution. Use is not recommended in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;15 mL/minute or receiving dialysis. Dosage reduction is recommended for patients with nonvalvular atrial fibrillation with a serum creatinine &ge;1.5 mg/dL",
"     <b>",
"      and",
"     </b>",
"     are",
"     <i>",
"      either",
"     </i>",
"     &ge;80 years of age or weigh &le;60 kg. Compared to warfarin, apixaban has been shown to be associated with less major bleeding among all ranges of estimated GFRs as determined by initial serum creatinine (Hohnloser, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; High potential for interactions: High potential for interactions (eg, CYP3A4 inducers/inhibitors, P-gp inducers/inhibitors, antiplatelet agents). Refer to Drug Interactions for in-depth discussion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Acutely-ill medical patients: In acutely-ill patients (eg, heart failure, respiratory failure) at risk for venous thromboembolism (VTE) receiving apixaban for extended VTE prophylaxis (unlabeled use), an increased incidence of major bleeding without greater efficacy was observed with extended apixaban therapy (eg, 30 days) versus low molecular weight heparin (enoxaparin) therapy for 1-2 weeks (Goldhaber, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Elderly: Systemic exposure is increased ~32% in patients &gt;65 years of age; however, dose reductions are not required. Dosage reduction is recommended for patients with nonvalvular atrial fibrillation who are &ge;80 years of age",
"     <b>",
"      and",
"     </b>",
"     <i>",
"      either",
"     </i>",
"     weigh &le;60 kg or with a serum creatinine &ge;1.5 mg/dL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hip fracture surgery: Use in patients undergoing hip fracture surgery has not been studied; avoid use in these patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Prosthetic heart valve(s): Use in patients with prosthetic heart valve(s) has not been studied; use is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Body weight: Systemic exposure may be increased by 20% to 30% in patients &lt;50 kg and decreased by 20% to 30% in patients &gt;120 kg; dosage reduction is recommended for patients with nonvalvular atrial fibrillation weighing &le;60 kg",
"     <b>",
"      and",
"     </b>",
"     <i>",
"      either",
"     </i>",
"     &ge;80 years of age or with a serum creatinine &ge;1.5 mg/dL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Neuraxial anesthesia: Spinal or epidural hematomas, including subsequent paralysis, may occur with neuraxial anesthesia (epidural or spinal anesthesia) or spinal puncture in patients who are anticoagulated; the risk is increased with concomitant administration of other drugs that affect hemostasis (eg, NSAIDS, platelet inhibitors, other anticoagulants), in patients with a history of traumatic or repeated epidural or spinal punctures, or a history of spinal deformity or surgery. In patients who receive both apixaban and neuraxial anesthesia, Canadian labeling recommends to avoid removal of epidural catheter for at least 24 hours following last apixaban dose; avoid apixaban administration for at least 5 hours following epidural or intrathecal catheter removal. Monitor for signs of neurologic impairment (eg, numbness/weakness of legs, bowel/bladder dysfunction); prompt diagnosis and treatment are necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Surgery and invasive procedures: Discontinue apixaban at least 48 hours prior to elective surgery or invasive procedures with a moderate-to-high risk of unacceptable or clinically significant bleeding. Discontinue at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding or where bleeding would not be in a critical location and easily controlled. Reinitiate apixaban when adequate hemostasis has been achieved unless oral therapy cannot be administered, then consider administration of a parenteral anticoagulant.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F14642518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of BCRP, CYP1A2 (minor), CYP2C19 (minor), CYP2C8 (minor), CYP2C9 (minor), CYP3A4 (major), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C19 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F14642516\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Apixaban may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Anticoagulants may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May decrease the serum concentration of Apixaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Apixaban. Management: Apixaban U.S. prescribing information states dose reduction criteria that may be applied under some circumstances. The apixaban Canadian product monograph suggests that any combined use is contraindicated. See full interaction monograph for details.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Anticoagulants may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Anticoagulants. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Anticoagulants may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Anticoagulants may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of anticoagulants with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the adverse/toxic effect of Anticoagulants. Specifically, the antiplatelet effects of these agents may lead to an increased risk of bleeding with the combination.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Anticoagulants may enhance the anticoagulant effect of Rivaroxaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May decrease the serum concentration of Apixaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: May enhance the anticoagulant effect of Anticoagulants. Management: See full drug monograph for guidelines for the use of alteplase for acute ischemic stroke during treatment with oral anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Anticoagulants may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse effects may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the anticoagulant effect of Anticoagulants. Vitamin E may also increase the overall risk for bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F14478997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Food: Grapefruit juice may increase levels/effects of apixaban; use caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: St John&rsquo;s wort may reduce apixaban systemic exposure; use with caution or if possible, avoid concomitant use.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F15868175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14478985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Data are insufficient to evaluate the safety of oral factor Xa inhibitors during pregnancy; use during pregnancy should be avoided (Bates, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F14478986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14478987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if apixaban is excreted into breast milk. Apixaban is not recommended for use in breast-feeding women; use of alternative anticoagulants is preferred (Bates, 2012)",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F14479019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16570441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Eliquis Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg (60): $300.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (60): $300.44",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F14479022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Renal and hepatic function; signs of bleeding; routine monitoring of coagulation tests is not required. Although not recommended to assess effectiveness, the prothrombin time (PT), INR, and aPTT are prolonged with apixaban. Anti-FXa assay may be helpful (plasma concentrations and anti-FXa activity exhibit linear relationship) in guiding clinical decisions.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     When converting from apixaban to a vitamin K antagonist (VKA), Canadian labeling recommends INR testing just prior to each dose of apixaban beginning on day 3 of concurrent therapy with the VKA.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F14479018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Predicted steady state anti-FXa activity: Peak: 1.3 units/mL; trough: 0.84 units/mL",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F14479000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits platelet activation and fibrin clot formation via direct, selective and reversible inhibition of free and clot-bound factor Xa (FXa). FXa, as part of the prothrombinase complex consisting also of factor Va, calcium ions, and phospholipid, catalyzes the conversion of prothrombin to thrombin. Thrombin both activates platelets and catalyzes the conversion of fibrinogen to fibrin.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F14479002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset: 3-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      ss",
"     </sub>",
"     : ~21 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: ~87%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic predominantly via CYP3A4/5 and to a lesser extent via CYP1A2, 2C8, 2C9, 2C19, and 2J2 to inactive metabolites; substrate of P-glycoprotein (P-gp) and breast cancer resistant protein (BCRP)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: ~50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: 2.5 mg dose (repeated oral administration): ~8 hours; 5 mg single dose: ~15 hours (Frost, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak: 3-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Urine (~27% as parent drug); feces (~25% of dose recovered as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Agnelli G, Buller HR, Cohen A, et al, &ldquo;Apixaban for Extended Treatment of Venous Thromboembolism,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2013, 368(8):699-708.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/23216615/pubmed\" id=\"23216615\" target=\"_blank\">",
"        23216615",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Alexander JH, Lopes RD, James S, et al, &ldquo;Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 365(8):699-708.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/21780946/pubmed\" id=\"21780946\" target=\"_blank\">",
"        21780946",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      APPRAISE Steering Committee and Investigators, Alexander JH, Becker RC, et al, &ldquo;Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome: Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2009, 119(22):2877-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/19470889/pubmed\" id=\"19470889\" target=\"_blank\">",
"        19470889",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bates SM, Greer IA, Middeldorp S, et al. &ldquo;VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):e691-736.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/22315276/pubmed\" id=\"22315276\" target=\"_blank\">",
"        22315276",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Connolly SJ, Eikelboom J, Joyner C, et al, &ldquo;Apixaban in Patients With Atrial Fibrillation,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 364(9):806-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/21309657/pubmed\" id=\"21309657\" target=\"_blank\">",
"        21309657",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Escolar G, Arellano-Rodrigo E, Reverter JC, et al, &ldquo;Reversal of Apixaban Induced Alterations of Hemostasis by Different Coagulation Factor Concentrates: Studies",
"      <i>",
"       in vitro",
"      </i>",
"      With Circulating Human Blood,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 126(4):520-1. Available at file://circ.ahajournals.org/content/early/2012/06/20/CIR.0b013e3182611cc2",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/22718802/pubmed\" id=\"22718802\" target=\"_blank\">",
"        22718802",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Frost C, Wang J, Nepal S, et al, \"Apixaban, an Oral, Direct Factor Xa Inhibitor: Single-Dose Safety, Pharmacokinetics, Pharmacodynamics and Food Effect in Healthy Subjects,\"",
"      <i>",
"       Br J Clin Pharmacol",
"      </i>",
"      , 2012 [epub ahead of print].",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/22759198/pubmed\" id=\"22759198\" target=\"_blank\">",
"        22759198",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Furie KL, Goldstein LB, Albers GW, et al, &ldquo;Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation: A Science Advisory for Healthcare Professionals from the American Heart Association/American Stroke Association,&rdquo;",
"      <i>",
"       Stroke",
"      </i>",
"      , 2012, 43(12):3442-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/22858728/pubmed\" id=\"22858728\" target=\"_blank\">",
"        22858728",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Goldhaber SZ, Leizorovicz A, Kakkar AK, et al, &ldquo;Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 365(23):2167-77.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/22077144/pubmed\" id=\"22077144\" target=\"_blank\">",
"        22077144",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Granger CB, Alexander JH, McMurray JJ, et al, \"Apixaban versus Warfarin in Patients With Atrial Fibrillation,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 365(11):981-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/21870978/pubmed\" id=\"21870978\" target=\"_blank\">",
"        21870978",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hohnloser SH, Hijazi Z, Thomas L, et al, &ldquo;Efficacy of Apixaban When Compared With Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial,&rdquo;",
"      <i>",
"       Eur Heart J",
"      </i>",
"      , 2012, 33(22):2821-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/22933567/pubmed\" id=\"22933567\" target=\"_blank\">",
"        22933567",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lassen MR, Gallus A, Raskob GE, et al, &ldquo;Apixaban versus Enoxaparin for Thromboprophylaxis After Hip Replacement,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2010, 363(26):2487-98.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/21175312/pubmed\" id=\"21175312\" target=\"_blank\">",
"        21175312",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lassen MR, Raskob GE, Gallus A, et al, &ldquo;Apixaban or Enoxaparin for Thromboprophylaxis After Knee Replacement,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2009, 361(6):594-604; published erratum appears in",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2009, 361(18):1814.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/19657123/pubmed\" id=\"19657123\" target=\"_blank\">",
"        19657123",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lassen MR, Raskob GE, Gallus A, et al, &ldquo;Apixaban Versus Enoxaparin for Thromboprophylaxis After Knee Replacement (ADVANCE-2): A Randomised Double-Blind Trial,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      ,  2010, 375(9717):807-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/20206776/pubmed\" id=\"20206776\" target=\"_blank\">",
"        20206776",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sharma A, Chatterjee S, Lichstein E, et al, &ldquo;Extended Thromboprophylaxis for Medically Ill Patients With Decreased Mobility: Does It Improve Outcomes?&rdquo;",
"      <i>",
"       J Thromb Haemost",
"      </i>",
"      , 2012, 10(10):2053-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/62/39911/abstract-text/22863355/pubmed\" id=\"22863355\" target=\"_blank\">",
"        22863355",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 85642 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.211.0.116-ED8D71C93C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39911=[""].join("\n");
var outline_f38_62_39911=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15868354\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15881499\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471661\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478981\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479016\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479017\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479013\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479014\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15869945\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15881025\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15869944\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479020\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478984\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14972349\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478979\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478993\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478988\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478989\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14642518\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14642516\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478997\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15868175\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478985\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478986\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14478987\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479019\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570441\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479022\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479018\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479000\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14479002\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/85642\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/85642|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/40/34436?source=related_link\">",
"      Apixaban: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_62_39912="Crohns vulva";
var content_f38_62_39912=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61865%7EOBGYN%2F69563&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61865%7EOBGYN%2F69563&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar involvement in Crohn's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 349px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFdAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0uO92QskADRjOGbgVSuHLozXC7yORzgD6Vnx3Vz5gDKnlkcN0UfWr7Qxtb/vZBKcglc8CvOlUc9j11SUNzMNzLI/zbjGckbu/tQJXBO1B83XHatCS4hjKkRhh0zVMiOd5ZIgS3T6VLv3N4vTVFW8HnQHcFwoJ56GsaO033UbvHlQMBfT3Arp4Eje3YPjf3U9qqTWhXLwyAN3D9AKnluawqpXRQikl08uFXKg8Hufw70/+1XlkIdQCTge9T29uGJkD72xyPSs2+CqWKbd459RmnFP5GiqRfTUmudW2QErkMp9ayri/uJI5V8zBPCkjnpQttLJEZZRGqu2No7cVrrDBHaHMAQnB9fxFXsNzSVkjn0t5jcR+axJALEEYye1bEduWIl2kBeP94n0qcBVYeYQQM4PTIqTCygJG2F9Rzii6Ik3IrrbpcOSy7j056Cqb6dDZ3HnEHAkUZB6ZBrYWB12+UQUIwRWdq8EiWzvnKBgcDv60rmb7XJo5rNr1wgL5jwcnvTVhKXCB2fYuGwTkc5rH8PrvnmaGNpCx28+mM5z+NaVxcEnyW+RkGQTx+FUpEOOuheMsVud4QMQOGGeuaz7oLeIzXDouT8iZAqAuJVBBZ0zgg9OtWFghd0aVm3KcgHjH1FW5NiTSNLSrO3QRIk7EAYZC24fpzWvHZ210rjYI14yB1b61nWckoVgsCbDkAk7fyFSSajNYyZGMcbhjBINK5lKTvoaMECAY2YGcZ65Has+b7NNctGGPBxhe5+lUNR19nk2xbwzDhFHzGls7ieN1eC2jt3H8b8vn6Ck+xUG3qXJ4BGiOXEWOuearRxmSRnmkkcbcxrnI+pFXGWOVAbq5YsDuClQFYj1HpTXmihMbmNmDdcDAGKcd9Qk29AaaFI8DJkUcYHX60y3tIiXnMp3k42sOCT2qLUZ5JDvt7dRkc8mqenXF4JRHNIgyd23b92tJSRK8zoLaxSKYOijcT07Grhi8wE/fZm/75p9iu5Vkc89RniraSRibfGpVjkkjua53e25Tm90VoLOSBg6nKjnHWntDE10ZY/8AWP1Ung/T0q/BdRTHaCA+OQOoqoLVTNIsh8yI4KseCpqHG2xPPd66GZNDNtkiZW3s4ZTu4GKsPZTSQqVQKe7E9PcVpJAI2RGTO49c8/hVaZLrz5FkJaNfut04o5erK5rvQxGEFvO8bDzSeWOMkGrFvFp0od4w0cvXKdvqO9PuLBeJHYAMRnjvWfLCyXYNqSCOMn070RVtTaNNVFozWUTyTox2KF4wRjeKvT2iTuvzFQvPyjj86gtJZJIdk0JIB42n9auwXEcKqZSVXOASMfnT02OaV09Clc2obaj4IbjK9asRxlgYxGwVBjd61d8yCaXarR+oIIzVgKBu6VPJqJzbRjQSCO4VABg+laMgJ7j6VVvIQJA4XDn7pHGDUKWl3jclxj1zyKlK2hbs9SzLII0YDjPAxVO5hkS2XMgDA8k1I0Em8NK4cHsBgA0GZXdIwSyg84q+TuVDTVGnZThYMnjA4HrVWVwX84gZzwKq3M37zbGcE9fapVbbHjAOO/vWspX07EOFve7k5Pmrl8Z7UVWaUgZIx9aKi5HK+hjQ+VIrFCHC9A3Oao3UyQ3PlxL8rDKhux9KuTS+UN5Az0wT0rLnmgudyyjMh5UenvSvZeZ0RTepaW/jVxHKuJmHB9KkkvIoF2RNsGck+tZ0FhKsbXcxDow+6Tyv0qndNIVkUFXXA2gdaXM77AoqWxav9dgNzHHGxaYdW7fSo/tm+PLOY2b5Qox196qada2H9rQQXM0Qnc7tshKgHtk44zninX8dtb3+yMlpSoc72HGewAq5U5JcxoqNtC/a22+dvMkkKYxtU8Gr8tnAyfMygdOT0rIGoSrKI9iMu3PBwRj+dXpNWtIkG1U+bGSeo/OhJIylKXQqyWaFj5dygbqBndil80htk+7A4DseG+npUV5d2zFWV1Cf3kGSPemedbT742ZgW+VS3TH17UzVSbWpYntFFwEDny3GcqehNFvHcWLAPF50JGcg7Sfwp1lGfs4Rm8wLwXUZyO1OnluVQBAGPZivQfSly21By6El3foqIkcEyS9hj2rE1O8u7hPIigIkcEAscAD1rTuneUKYzzkE7R2rK1XUIoJeWKrGSxz1/wAnFUrvUzlJJEWm6hcWETWkDIAZCSBx+verd9e/ax9n2xg4/esR0PX86ydDuUvN6XC7baYMjkdU5BBHqa0l0pIpEUFrhd5c7P4vbmrSbjpsYymr2E8uWIx+WFdY+QfUVBJeTXl44hti7M2FJOF+vrWnFMvmNEbd+OEJYYx6Y9adpEO6SYPbzojNgyBc8++Mmq8kJO+rKccl55oVt7SYPyqCQKvWxnuZ5lvJIFCrwBkn8fStGBLCKSSKV2Z1wyvt2lfwIyauxQ2km5nJNvIhUueACeh9qqFNsHJLVoyreyeRTcQx2+xV9OoB6n3/AMKjV2nlZDcYZSOVGM+nNaZtfJguIo53QYw2wDDDtzjNZdyXS4giEexFYDP3iSO3FNx7hJx+yWpDJFIHSHOf4x2HrmpbSVry4ZITGfLXIyf0qaSaFgfNi2yhduGOf19Krl1WPAQ5xyyVE4pMUW5FmSOW6VjLGQyDHtUukaXFHZ+bIqNJ1b3zUZu2Di2DncwwykYIHqatuz4YK53OAuFqb9S9Xoh2xY4ACuVY4wKzvNZrx0VXiwcKD04qSJnWRRJlSO2OCakUbrxRuAY84I4z9fSsZRubpWVyayMhDuzKrbDkY56gf1q79pV4QFk5B2sKqy7DKZCuGMYBK8ggMDzUJnSWLbEdrKxPPGalxtsZ7u7NyzuI7aJsvk9ge1RTXzTSfuwEyccjIPtVK3dLq2UbGUjr9fWrdtCqoGAU45xjpWnM7KK2I5Yp3e46ZY5ELH5G6YPTPtVOW2CuVYbZM8CtKM7o8FQVznFKqRmcIcZxkZp3TQQqOOxHbgpFiRdp7cVchgDx/MSAORmkkiIUKfm9zT43dYsfKP1qWlchyvqhhiXOSiOR6gGkkARRhhGfQdKCH5YjJ9qi3hiAykgnGMc5qPIaRYjTzEy53FuufSm7HjyHPy9jT/nQqAcZFSRZuHOAcLxk1UYh5lW4iC27PnC4rNt48ZEWcDn3NdBqEBNuFK4zWS+y37YC9SeprWUVB3LhK8bIiMLBgrLz1zmrflKkPIAIpttmVvMIOOuDUlyS5CggA8ms5dWKTbdjOuPM2lgOKKsSruXaDgY5NFRZlRklucFdXccS7N7GRhnaV4/P1pdNWGeNdrBADyT95uatLp8E0Rwu93AAJ7e4piaWLZ9rgsrnJKjPFKzR08yirXHyI0Jkw5YA8A02LRbpW+2MxjiYchhwCe9bVtYGzd7uRhPbqQDHIfmGKmvfEVhcxrHLEV3jbgjPFbQhFaydjndef2Fc5e58LTahP9rhVRKo3uQ20FR3qr/Zwt7wXMqCGVl+UDgP6GtuO8axu2j01pI4SMFiT0PYA1Za3kuUcXDyTzZ3CTGcD0rW1N/DuaPFVbWlt+Jz1xtZ1ZoSUII3BuKsv9mlAMqloSApibqPx+tI9u4ufLEJkydoAHBP1q/LoU9uYbg27TRFcsi8kZ71KjzPQxk+W1ytc2EkNhIsSiRSvy7hhh+NVdMhx5b+aqyKNrK3at77bdC1+zvbiWFULoV5Yr0I/CjybWO3guBOkUzqVeAr19NxrR009UT7d9iosHkFzHKiv/zzB4NVkvi6SMomVlXG3bkE+n0ptxqhtyUa3CljtGMAD8afNcraBXlkDCQfMqdSKytbYOdsyr+aaSUzCFlDALuHTPcY71kX9pGIXnuc5zzu6kCuntIWupRc/KsHJVnYDYB6A9TUmr2MEs0NrZ3UEwn++pPyxkdjnp3rWNO6uZzqM4XSQoumukDKkbEIvIWRuwPpW2dSktCHu4pmd/nO0ZAPtioYm+zah9nt5T5SyeX5ZXIwTyeO3Wt5LWTU3bdKsewbX2gYOBzShF2YOXcu6JDDdWUbKIDv+clmHy56cVsW2nSFWFlLHbKx+YKmQffmqCKsCIrqWKoFjyhbI9amk1BIoSyr5bH7zbsYP+7WiVtx3b2HiC7s57lNS2zqExuQAjBHcH8Kz7nU1tlV1kEgPyvEo3Z44wAOPx71e07UL92WSSRGVycYXlx0xU80TNdWyxWcbTk7+RwoA7e+ae60Btx0kipZY2pNdljOAcRx8BAegOO/1qW4uvLDMbUeaXHrzmtSysVsZ2M4kWQjrydh9TVLUYN91E0U+d/yjeuBj1ocWkTaLdxbaK3dy0lsWnxkhTgJ9TWfPbt5n+inLluCGP5DNWba2Cq5WQmNScurZ3j8arPqKq4Csu9CQNvGfp61m13GtGPhSSCZgsW2bbyW5J571LEHFx+8dnQjgYxjmmNNLGrFnyzjJdgOfeoYpRJIyyTjzG49vzqLWLTuSwxyC7Blk3ROxz3zV5rJUuPPDPtIIUf4VXtI7i7lH/PVuCBjHFXvOkUiJkXYmVBx3p2SWpXM9kysokxKIo3I2kc/n/Skj0u4ZQyr8+e1aLI4LpCrYaM5cHvg1EbW4QIElZSgywBwSalR7g5dtBtlbeTO6EZOeSeMVcSCe4UGEfLHkfXmqlgk218yMZN2Gz39RV4SypKRC5jCkEgjqDU2V79CW3cjPmABp42Ug8c8flVtBGzht2zjkn1pl/dpIhiIYu3f0pkCsFO4jj1POPWlJK+gtbX2J55oxxG+4+/GKSKRnVSXG4cHFUXjUXTlm3O/YdqmtoHjkbzAFYkYx3FQ9XojRQVi0xk3As+EHOMd6dE2SeMEd6lniRY1bLHH3lpFgWVywG1Tzn09qv2bIuia1h807TyM5JNaUUawAquDVNnMSqkfJ7mrMfyhSTmuiEVHTqZTuyPUWxESTgdjXNT77m8Qqv7tOvvW5fSfaNyKvyjvVW1hCFgazq6s1pv2cb9R0QARjj5RxUOPnznr+lWpQFj2rxjk1nsTtweST0HaspPoKN2KgyzbhkGilw20YxjFFTYlnMSWsaHbbSyqV5DEg0yaZbVEUTPvHO5gPmb2p9iVvywDlEHTcQM1Zi0hWUTSuHTOFVv4f/r0JN6o6G0tJMxn/tGcG4lkYMThlxgY/wARU2n6LIbzzk8ye2XgbQMZPPHtXQto8rW7yY2wk/3s49DVnRb1tJtJYlhLyNnywR1Hdf8APatIUbv3zOVaytAozack12I0tpInVeRI3UVvwnTbOxltJUdbhF8wA4+XPTHrXI6nJqN9d7pI3hEfKyKcEex9qWOzvbwiXz45ZiuFG7DY9PetYyUX7qM5020uZl651eCGCRrKEYYEPuX+VYNv4jv7eQQMXWPoEPG4fWtPQ1jt3nt71ViulPCzHAY+orduYtMntxmSBdQiIdFyCr98VaU5K97FOVOGjVzi7rUb+zkubvTLf7KjEeZGV3cYwTn1pNPlhdPtTwtOZRtYiPLAf3vwrsLrxXp8el3FpNpy3EsgJAiUELntn1FY3htdD+2effQymK6+V4mBUQt2I96qMLPe5Epe63y2GWmmO9tIlxE0it034XB9v/rUy0022tUdCwinZv3aMRz64B6ivQJpltp5Ir/y5bEJtjLDrjnOR3xWRrVpp0OjCVo1kF0wWMP8xiJ7Z9a19ktzmVVtmBfWiXsSWU13EL9zuhgVCpZQOnHTNY8HhG3tbadr3UUj86QqERyD9Cew9TXoNtBZy7C8EJvoI8whm2HPQ8jg5PGOaxtdsLNdAvNQ1iMw3GB5kcRZsE8qoHpjnNDgnqJVG3ynPaboGkafq3lGS4hXT5CPPwGUlvukn0P9Ko315exXc9yIoy1vKN0Qj2Ag9wfU11ms6StjolvHoSxS29xGXmeXcplIGVxkZz1rAsLuxM0V1ZpPtyUZpyGDYHRfxzx7UnCystCoyu7vUfaXlze2yxaeRGGUEef8zBgfujHQdxW3YWVhaavaw3lrcfap/lkdE8yMN657ZrPure/mnivLhza4+QSL94r2B9q3knudGSG1EH2yWRvkKsBuHpjqv16U0u5UnZaG5qXh+1SDzbK22umXIyF69+ehrAij1HT1nknjlljYr0QEqP51autVvrWRRd2ky2867Ftz1VieMnPSrUV3JdGzha4e0uivl7VX7xHbnqPpV6ERcre9qRNcXeqB5jH5cceEIU/Mfwps+iKu8yNuD4WNEGT+Ppz/ACrcmtbIeXtXy5TlMhQQCevJ6VSk0i3sfMmtAOSNySKPn9T9fcVNu4KfbQy5tNXzU+0oIgg/1XZsdjisC6SG7uvJktI2Kk+WmcbB7mtvULhj86QZjBwsjFvlb2b+eaLTQDMJ5lvHjudgYcKFJHUZxUuN9jWMrP3jmru0Fl5Rut7W7A7XVsqB7Gm2unG5ileEqHc7sMMBf8jFdTblzFJaXluwgQZMj4I39QAPfnNEcUA8lpExuGFCjGTnv7e1J00ypT5XoYkFwbMxRRuhYgtvA4PsKY16zFVuVy5OSMAAYrbn8PyQSq7siiUkDAyE+lVv7GNu7pdlZIhwMclh61jKnLYqNSD1ILO/R5NsUIXII4bPODWnHIC+4j5sYJFVZNOiXM1uFjTJwhOADimwu32cjcDzgnuDUqMo7jfLLVE886oDt4A6+lQy3JkKswPA6dwKQzMLMxY2buTu6ihoFkmDi4BVVBOO9Fm9hpJbkUoaYR+RuDMcHjpip3ZoAg+XbjrnrVdQ5uNqkjC5Yr0qcxb/AJiSSvbHesZR10NrWSvsHn5/eRKRnvjrWjYRlhu3Fh1qmqSsheRBgjOfQVoWJaaMiJCIl6npzQkxS20LLQhpM5IyOc0sYUKVQ5ANTGBn2nGVx1qZIER1YKAwrojTMbpIijg4ZsZ/uinNthiOWwT97npUkk3locjJz09Ky53E8oUswyemOtaNKKErsSKRXdwNx96lSPZlifapIlVUwAAe9NuGynBwQa55Ibd2RO2AQemKoyHL4GMGpppCV4quuNucfPmsG7mkUSPvI2rwAKKfE37v5vzop2fQhmA+kWSlUaF4J87c5wPypouvsUT24ivJ3VsbvL+U/Q56VOt19qu538/7P85GZFz/AJNbMdrJDZMzzpImeo7V1OKfwoTm9OZmXdXN3f2MMSxeXK+AFY4/SpLy0ubaLzprZphAoIdZNoD9gPUVt29rDFdL9thkY7f9aCDj2xUKRme5hijdo0VyVWRd6sauKfUzc1stjJt9S+1RwG7sXt0ZSRvB+cjrjFSQadLfXxmjZLLCb4yWwv0z61Lql+41G3gMRtgvCxqM739QewqbV9IkvbMJLdGBCcESPgBvWnGN7rewnK1raXMHUrSylgUa1LKzPJhWVfmVjkAg9xxWXeTDSb22sI7DyTOQGmlIbcp9B2zWtq9vZwFFa6+1LbqsaSiQ7YnzwQOlVzq1nqOqtJfWnm3EMeyOUAYHuR70nFLyZouZ7ao1tH0vSdG0W8ncBtQHzLG43qSfu4x0rP8ADdxO1+Bc6aRalD9oaY/xc8j3p1pdxx3MUcrvLCx3OUjLMrAcLjuK3PtSadpYkWNZ7i6uVZFLfdXrmtY2toYyUldPVsp2Ykt7/wC2WVxE1nOFg8qZS+1ucnk9cVaGi+XEZmnZ7fzwyxlfm4OCcdh7VVijGuJctp1pDHK8zTLI/wAw3dMDP3R9Kgt7C/sNNurTVS8iK5dlt3wOTkE4561d7mPLbS+po6FaaV/ad8yyzmC0xu818DqTlfQ5q4vjLRZJ5bdPvBMfv1GZNvQZrk3sbmW0NxqFvNDbABY2D5z/ALNY9zfxafq1r/Zdp84P+seTdK2e20cE9etS5cpt7FS3d2dFrfiN/EuhmCS9tNMvoJTiSPdKqjsTgccGvNbaG4tNViWOV5I43zJgEI/H3gO1dPcQXE8LiCI2V3g+ezqSpTdxux0rPS3sjbLMkh8zeEcI/Rj1IAPoKiachwUYXN2PxHpbaXeG+WTzSoKK0pHfr6k9+Kjs71rfUlSya7kmKZUTjY0begJ4PJHXtWKLSGWXzNHtpIZYwN85kAbIGGCAev8AWtzwVp8ckovNRvZJp1YyEALG/PZi2C2cAjOcULmk0inKKV0dTZ2d9eRLNrF4sfktmSKBMM7jucnaT/u/4YvXN/ewz2xtrONhG+CGYBj6NnnHXp159qoXGv75DHc4WNGw0cUnynHqSO/XioZfE0qwTmCzVI5CCsUjA7j07dK0bS6mcaUpNaG0L64mkuv7RCRRnhkP7zIIyDkdMcUWcyxG1tIriaQPnaxUthfXPY1iRX4uQJJldWJK4U5HfgKf8KhnvpFmhCS+Xt3eWQOWODgn0NS5o1VB7HVKcStaBGRIuVzwGXnp+NUr+CWdCVik2EFSVwrgeox2+vrWdY6ndXDrCfLOBlXIG5gOoz9f51YuEnB2wsyTAYcFy2fr6Ucya0I9k4y1KNsj/aZ/Nla544JGAPw/StDTreeG4NzO7SYfITGQoqw1xJ9oijECbF4aROucdxVy3KRNvD7hISzYI2knuPSmkRO5ciPmFhOrGOQBwQeQc8Uk1pDdzGV4FQ52kH2qGa6S3hlkeTDDng/dptvqHmWKSpHJ8z5HmcEnOCaHYhJ7oo3tl9llkiEHm5AaL5mwR6Vlpp9wjb4yiAtnYqZ/Amunv794zbxgnzSME8EDPpVPZKJmkYqyDIwDnOahxTN4zaRn30TTIC21GK4ZU559qr29nClqwZWcdCx5P6Vp3EiW8IRIfNlPJA4A+p7UtoyvG0JCRlzn1B+lS4q5Sbt5GMykxOwUjccZ6Zqw6rBbLCjAyPhgScVLKsizr0MSjHHqakECtcKZih7JmsWrGyleyL+lQxyoFnHBByT1PHSr0UAVI1i4HOcVHa/JH8g46YrSgiwuD1rSEboxlKxBcoiALkE4BwKhQN1b8Kszx+a0gQBjtxn0p8MR2FsHjg8dK2S1M+ay1M+ePKsSeSazpVQSlk5xWtPxub8qyQcztuGcd/WoqtI1hsWB93cRiq8j722gVM7/ACE8E1TkJGMEc84rlmOKuyGdVUewNQRKCSzNhamnceXz61RkcgNt45xisXubxV0XwyYwexxRVS2DblLdcZoqjNxszmhH5ryKCJXUAksmACf9qtzT7fUdrSBY3gbCtGvYD/GsvSofL+3Wl4snkyICjBuF56n2rc0+CXTLrZa3ImjQhg27gj610xXVjqzWyL0Ny0Fq8s0ZgRfkUlsjI7Zpkt+32eS4s4XeXAIaNCzZ9sUlhPbXj3Zu7iAhHGI34wepz60tm7T3DJamSKxjQhnt2HB+nYVskcjstWjN8RWcl7pUU3n4kBDM5GwgHqPm5zn0rm7kXdv+6vZzKkq5jlRyd/bn0NdYur2ZsRZ6okjTMxGWVgrIehz2zWBNqWjI7wywee6NhTnaRUTXVOxvSnJaJXFsdBivYoluJI1ff+8TkkKB949s1rLpGmWhUeYpQ/fYnn6fSudi1a0tdxknZS3KIh3F+ejfT61dtJJNTUCbyjCGPlxjKl/y7+9JOPRalNVJO7dkatvZWsFw76eJBFMA2Q2FJHetHVbiJbFRBbW/mty7v84UewPQ1k3N9aw2sdrE6F4ztCF+N3r0zVGG6uP7PeVLAzCM5L7sd+vqfSr5lFWRKpOTvIlksr6exK2V8sMy/dQg73yckHHQVm2PiHVIhNY3FvlFPPlggA5zn3rcu9VMmlOEt3t5whK84yfTNcrZandzKQivKUOJHwoH680N2tZnTTpc0W5JE1xq094weZt4iztVs5j/AAqtPqNwIYbZoQbNG35I+cc9Qaay3YZZbiyn+bJUqv3xnkYFaEU9lJ5MSBuV3Angge+am7fU6JU4OySv6Fixk0+dxcxRzRzy5LJHgMSeAMgY75IrndR1ea0ujFaxQB2m2mSWAAkdAwyPvcda62HThOqmyuoyWHT0OfSq1yl3Euy7QPGAVy6ZB47Ht1rS7S1POnh430+4yLmHULG2CXN6C1zmSWN8k59OOlaECwvHE1zCRIFDeZCQzfhnoaS1it43+0ALezAt+7ZAFHHBq1pel7gs2zyw5IwsmTux0x2HWpHBKK1EjhtJonjW6EpY7iju3mAnsR1JOO1RzxuXjtogvnxZOc4wfr6VbTRXhu5L7zM3EWF2kDKgdCfrk81a0+1Rrp5pwEZhy5PApSi3oaRmld3KWn2ZiuGiaYornc5YDJNX5rFZXjneTcVGEyfTj9RWP4i1aHTrn/Xxzjno2Tmsdr/XdTfNjbv9nGMkjgqfSokorRnbDDTnFVG1Fd3odo88Nr5aoQJQeATUY1S/sA0kcQkO/cOck1iL/bcvkxyxRxM4zHI57jtnvU2n6xeRanaWWs2+YZJP3k0ZBAHpxQpdNUY+yTTs0/n+R0rX99eaWk0cUcMjEFw3tznP9K0bGSe5s7dQq72OQ24AAVKYVCOsDAgdAT0FcnrVzPbzSQxyA7iQNuTj8RW7vHVnHShGu+WOh1NzaJuaV0yCwLAnoB1p1o32lCuw5VuAG5PpXIaPf3UKBN++KRCHVweD7VsaTqKW0iQOM73bbz2wKnnTCtR9m7J3NpJtiSL5RDklWYnH4VWnumt4SAy7shQUPApJIrmKwuTaldjdSQSQSeorIbV1sj5dxklTlww5FDmluRGLltqdRa2jPAwjO5JOTz371QNnHHcZfKiNc/QVTsdckVt8ayLCRnngH2FX0nS6aJscFCGzkcU3ZiUZRIoguVABGTnJ6AVLpe258xXGTG5UHHWsya5jgAUuC7vgH1rY0JAp3YOO9c17y5TW1ouRswWuHRcYyegFWpRsVynJB259PrT4kXIlcHI5AqnczmScYPTg4/lXTGPKjmTcmWbWHEW9hgdeRyabO/z70O3A5xxUFzeBY8K6uxHRe1YZvJpLh127UQ4POeapuxcKTm7l/UJsnBbkjkmqcXEZOc1SubgzSeVznv71KeB14FYTldm7hyqwu/nBA+YVTuSI5QuctjNRzy7H+XOG/Q1WlkwylgQ1c8i4w6kpk3px196ayEn3PQUyJzJOccAdamjyJsk9uKz3Keg1wyKsmcMMjFFPRRIWBIyKKLiuupzV3LBBfRiSeRrZ0Jyh5B7A+1aqtBZLaPOzzwzICX3EAH0wOKwkaC509ZBIY5sYcKMk/hSaZDBcWtxagztHwyeaSwX147V1pETirb7HQR6NBOJZY47dIzl0mzkn29qv2DjSdPZ85JOHdSCGXPdaxNKtmtpvszyxzQkfeQ4/SrZ1dE026t5I1LRAlcgAkZ71pC25jPmfu3uZnjW4j1LVLVLe5EMLgsccMSD6elZ17pFxagHSITciXnPDKV/HnIrb0nT9J1LT7i7ZlOpIMJB5YyvufasDSb2bQIr2e8u3QI/yIcFc5+6e4PXvScFJ8z6lxm4rkj06dyI+FGtp7i6u7uPyYhiUL1jY9B75/rUFvqs5kEFjbhZlIiecnCxKeuPen65qMep3L3dldyNFcYlNqx+UOBgDjqe+ao6LaanNMvnhIYA+MEbVBI5YnufesnaLtA6UpON6jOz0q1/tBTFYIVEbE+c6gsSOAR7VujRNlvHaXGqNHISQfnPBPc4965a519NItms7G5EKLkSTqvzP/wDWrjDrF1LcNMLmcyYJ+pHIOa0TjDTqHJOorp2X4nsd/o5t4kWXUbedehLsM1y0ttHb3creWfsrKVDkYyfeua0nxNc3mpx/2iyCKUgHn5VOOvFdelxa3YaFQzQ52FlbcpPrirXLPVGT5qWkncitRZMonVTE6gBWiYgfiPesq/sbmOQz2oieFi37xc5GfUelT2sbCV7RJJDb9Rvjw45PGOvvVwOltMscQCRKcGRgRu/Ck13Q4VeWV9zFsBtNo1lcBdQYsJUKnaAOnP51sTLdT2khLyyBgMq3PepLi8soY3Xz41lfn92gOfx6is3TtTkikmiClw4JV+hGDz/OpSUdLm1bE+0d0tu5FKfKVMxOpGMkensK2dJvTBE6xwSyR5wrsmcdz83Y1j3Oq28tyLRXAdmAb1Ga1JvEMVvZNp1nCrusZVFQA/N6lj0q7W1uZcrqO0Y3I9SknuN8cbOEYc7eTj0/lWF9iv7pfIlnniXOClvCzsR+PFbmjard200ZuIIt2wsQqhT9av6j4iW5aNLeMWu0EAuTtyfXH86mylq2aSxMqD5Ix+f9I5+28JIxaS5inEVuvP2t1Vnz22g1p6qbu3zb2txDZhlVT5XMYwO3PNR3Gv3CzxxNHHGGXD7BjcO/JOSKxtQ1F2fGzaEOPk+9TcYpe6Z+1qVmpVHdEVto5vJC91qF4xTnzJJf3Y9eK0IkstI8sQTPcXC4yyMCfrzVSS9SKGO0kUwhmLEk8kH2/wA9arIIyz+SRJN91GJIANJRS1HKtKro3p2N3+1XuvNQeYHydpL5GPesjzprefBeeVmIdBuyvHb2pY7O6jhaC8MdvJJ92RiCv4kdOlZywXD2c7LKwMYyJA2V/wDrd6JN2IXKtL6HSL4kJZIpLYeYOQgGARxVeXVJJJ5FWNYkSViokPO0qCOfXINc3bX4IQ3DuwCkPPtyE9MY/n61qWGj6hfxtMSoWVQ4+YZAB4yPWs3KUw9nCmtTsfDfiCSbT980q71ONp6mpNTuVzGLm1hlMzYVicAn/e7VzHh+1fzHtnA81CDvZex55Fdbe6i9xpbJf2UME8anaVAIkPY1pFu2py8rUrxVxmkalJ9mSxmtPMcuWiVWwVA7D1rYtomaczQv+7KnKhcY9cg1i2sMLRRSNG5Y7SAw6evP16fWtmaZBEjpvDJjexXGR6U09DTld9OplzWHn3yruBHoOmK6OEm3CDHyAHP4CqVmVe+afGA3er2oyCG0Abd83IyMce1YwSu5F1JOVol+3u8aeGJ+dhzz0rntT1qO2J2ndjJIB59zVS51MzOIhMsKkZeRz8saDqTTIrJtbZEt7bybFiDDGwHmScffkbGfwzitubTQ7KGGhSXPV2L2ma3HfbAkMgHRpCOMk8Y9sUvh+ISyXCsxKM7GM564NUdQgtdM06K5tpJQFRvMjdQACODgVtaFZzQ6BFM6BXZDcMDxsDHgH8D+tKLblZkVZQUJSp6JuxmzMF1NoUUnod3QVculZMJwOOSDSW00cLyFWLu4IOOw+tMmf5wrKd2PlzUyW5i7tozrmMvCzE4O7Ix3qtMT97kdMKetaMu0wY38ZIHFZd5u8yMIQNrdQO+KxktDaLvoLHJsVsElieCPSp7feE8xu/A5quABCwI5LZBqZBiPPocZrG2oPYsxjCu38R7UUsDHJyOD0oocexmzz+7Wa3nYpIQWIYHGQ30rW07UpLW2RpbcFy3L99tV7PZcWzyTBdq8BAeR70mrXFikEBiaURyrtKv/AAt7VvF2XNcppN8jVyxI0s06z2gEsUj5ADYZeOhrY1XTLaZbW9iiMiyLtlKnBRvp3xiuN01bi2xb/vE2/NExP3lrb0fWp9ktlINpdgVkz90d8CnCqtn1MqlKVvde35F46dBn93KYZUbh043DGR+Fc94l0CdJYLnUo2kj+/HCDnzCf42rpY1CXk0eWkjYbmzlvyqpqJlCL5J8t2TI3gtsT2yfWtZSTiRByUkcwbv7PYFrdbczBiFEaYIPrn0qjCviDXFUX16UXIROMbR2IH+cVuNFb28MccaErH98sByc5Na9tYwzw3Rh8w3FtiVZFHCjGcYqKcXLRs3qVYxV7a9zl9R8L30BitzuuoZf9XNGDjdjn9eDRf20NjaxafbhjeygrJ1Crj1rfh1DVLdrqJphv3BgQMBwRkYzxnB61gXOi32oNJJblPtbffCMS2O+SfTH61o6a3ijNVm9ZyMhytqr7JGaQfefAxnoKal/cWlgfLA8skBnz3z1HemXFjKl0tubqOaT+PH8BHUehqKC3huYZzcu7BCFQEY3VKCUtLnT6dqV7MqyJul2JvJzuwAcfhWzM4vbJZfPiDEZYA4B4zjH6V5/LC6xiS1clo1I3IdhUH1HeptLguZ52WS9jMSjJBbbn2zVp9DDn+0zfgti91O8jRqoYDK9BgAgfrWhBcjSr12cbw+FU59awtKl8i5eC7+XaNzAHcWU8fjzip4pre8gljbIeFSwbPLcfzpwViHJS6mN4nu4o/EX2hJUTewRWHODWv4V1tLWZpLtTLGHO7ClT9M1554rjzpsTo7rPEwck8nIPFdjpusWj6esl4qiU43IODStzHbSxChBwlqmdLeasyTPdXkzO0ynDMcsPQHP86zpdQhjkgSQrIU+dgc4YE55rnby9uNW1dPMdljAJOB8oA9B+FWbC2E17LGkbToFLZPBwPX0FUomEqt0egaQ0Fvp9reXdpDcnDIGDZIXtn0+lYN5cxo9xcxhmMjbzuXGPYD2qrcpqmmC2FpFIEuUDhdm4ICenHQk8j61Lf3F5bW5N7AY9ynLMoZG/EdKNjkjJ216+ZGl3ZLdtKIi4MZbaZeWI68mojPqEVp55sxJauuSdpAX0yapa1MJprSCCzFsioGEbNktnGWz74q3ZrdkRi4u/scWSDhsBgOmQKltHTSTS0JYpI3twtvd4klU+cjrjbnpye2asXGky6PZ/aZXm3ykFZBzFKv9aoG0uY7qRre2V4mcpudeoJxyO4z+VdZos6zpp+nav5iQwMxQucxrnt6D8s0RV9BOb3MSBreXSYvsqSQrHF/pIYgl2B7AdunXmpbBLu58ma0Z4N37uQk8kDGBjt1rcvvDUumSSzhood/zrxvBTPHH0qFpnuFkWGVoId4A2p94Acc9iTipkmnqaxakrrUXR7YW7y3CPK0vmbGyx5JrdmtxLGWMqjHD55JA7VVt4DHBbwbGLLkksedxOc/kTWhZASsSYijbQqkt/F0P0qX2Kb+0iWECC1AzuV9zRgdSB3/OoLmZgViiJLPhpE65qW5i2x/Z2VwYRhGH8Iz0FLpULJdmWf8AeA4HmAcflUyk7WNKdknJmhpUb+V+8iO053Bew9aPFMsiyxwrKJTtAGTjC4roTAIrGWRfLIZMdemfauGmvIdPkuru4bfIilbdWTcrOfX6Dn8qpJJWIoXrVbxW3QrWkX2m8FsGHkgBpWAxvOchSfQY6V2lgkkaiRMhcHGYiQT256Y+lct4cZLNoTeRGWN8llJxk44NdVBfS3NpMvmSpax4RShxgYPyn1z606b0ubZhKUpcq2Rz3jtIna2tYkQ3FxMsLxopXJJ7e3Stm5sZLa3W3k2gnGQh4GOO/WuV1m7lu/GOkQW2ZGiZpTxyWX+fArqtZvSY4/mBZUG5j2yKqDTcmVUpyp0qUO93+P8AwCOGJIhkDPIGapXrM14SGG0Lwp71kWGtEo0XDYcnce9aTMJSJJAFG3hqnmUloZypuEveILiQbGRclyQuAOgqvIBuaMEbge/0qfINwpBCqg647+9QoB9odu5O41nLUd7IRsrGqsBk89KaboK6xheD6027kw6KDjjpS2mGl3yLnHrWEtJWQ0tLssElYy4II9KKapALAkAZ4+lFJNjTS3ODspGW4IO/yDzuCmp7mxaWXKglPvjBHNbaWaSWgUsGkVPu57VXWFI1SRyCiHBwf6VnJNKzH7S+xgC1vkYyu7Ng/KO6iujhtUuIobp9qKPvjPJNRyyrPJiOFgoyAfWq91byw2bgsFOQyAGiL1fUltystjorW/tY5d0Y2hVw2eTzVe8aFryEuHeIH5WUgDB9a5mVZ7u3haMFZA3I6cVfguJBdR2lzHhDj5uua6oVLqzMpYflfNct6hZwNP5lu4KyfIyE8j3q9pBhsZZBIXMkoMbkHoMcHFVrofZtQzbohgEu1cnLAEf/AK60763aLT0nhhZyOZHU5yPf6V0wVmznm00k9mYPiC306WW2aOSSCbyzv3OSOPlGB9a564mvbPVxdxXDmCQCLcw2/MRgmu1021stWuYp5tqSJCYwzeuc8fhXLXUyRTXELyK+58BiM7SDwR7Vb7kJaNeRyayC5uZIoMo8eBI8nGST0HvU0VpFFHK0kUsyr8se59pDdzUklzZyalGk0MjNJ/y0XC7cNwDXXXNvYWBsLSeMP526R3X78Z9M9xU8lxuq420OGL/YofMVZY2ySHJGOnfNWrW5Z9OllWOPaR80kS8g47Cte70p9RFxcWzJcFSVSDH3E/x+lJLaQ6VHHA0e8fxkx/L+tKziZNqd+5zySQXxV2leIoMI5+83sT25zVW0ux9pl37l6/Nnhj6CtPULSOOOJkiRi27bEW4B+p78965fVr0W0i28sbKzDBbG7b9c9vcVN3vYiOmxFqUwuofLKqqAlS/Tv2rMs74+TtGS8ThTk/My57e9aU1ssSAoEJkHDAZUH2rkQkv9qt5snloHL7z6DH59a0js0a1VblaPSkuoEQKNxB/1ZYY5NdHZoYLEeVIqtcnfn1UcD8M5rkPDkwu2knjDFBEzBgSMY7Y711WlXazxxxyw7rlXEaTAYAHZSB/On5i5o/Czca1nm06K6DmPHzRsWxll9KzbmI2ujXlob4Mbj55EZc9M9PxJ6VL/AKNHqEQvryKTaHCweYU3sBwMjv7e1ZsusTLPczaRDG68xsJoRIVX1XI69elDfUOZNJWMyy1Bhc2IWPzXtPk8xkIDL2DH1HqK2tJ1B7oN/aMKPMRhZMH5MdOB14x71JpmqrNqOk2dnps7xxyK0rS7QJGA5yxPTHb/ABrtL3UNJsdUu4fszRIpDI5HytkcnIpcul7h7TpbVnMQTXE/mtBE7OSnmeYm3GO657E1rRwSGaeK4iGJGVopCeUb+Ie/rTr0tdNbJbK+ySQCJA+C59x1wKr3N6tuz20hd543J2fdGRx+Pek9NS4xb0Rt63IZtXct5kicR7EGFCdOB+tSXUS6dbx2sspKRD5VQdSehPfOAK0dBYy2DXDW4kLP8+Tjywc9ux61Da20d2k7/f2Rlh/t8nAH4A02tSlO6s+hStbue+MEjxgDkZPU9s1qpIQnlJCQMDa3ofU1S06AlCIhsi3/ACHP6VqxIxnVjuMeNpCDk+5rKzsaSkloR3MkgQAEAsRuP86n0rcJdpJ2le4/WqN1IJMYjyGOTnrkcVr2Y/0cybcBRjGKy3Zey9TRuFT7GhQsSxOR2ArhPE8qL4ksNLRUIT967L/ExGcH6cV29jLHcjynLbCByPT2rzMS/aPHF3OCBBGCiArjjPcetVVdo+p3ZZStKc5fZTf36I64qrttbGcfLirFnqIs9OvIJekqFRkd+1VLEI9wzE5VF4/Gs3xBcx20BeckRr905xg+9Oo+VXRhSj7afI+pQ8P+Zd69qEqoZLhAtvCBzy/B+nGa6S/YnzUlZcN8vy9KqfDqPyrOeaVTvZ2lVlbG9yMLkewNSa981ykSEAAbmxRFuNNeZ14uXNiXBbRSX3GOmyK6KxjKDkYHU1vwqLm1U52jHT1NcoHMMjvuJQNzW6t9DHawKu7ZICc9MHFRSknuZV4O6sSXMpR1TOEYYCEdfU1UupZINhA3/vCuO7Cmxt9pvIZdzMVyozjkYokiQyM8bhipBHPX1qnqrmVlHRivh7hs5YADg9qnMoVhgDPT8qx7m6XzHWMYcHkk9Papba6DMCwPHSuebVylB2NOME5BOe/4UVBvd4Cydehoqb9kHI31OPs9sd5Hby3JXd0ckg5rcSG5SXZHIjYGAT3rNv8ASfOvA+9VGchvSrdv5kEoUsWAwPbNZyTWgnZ6ovXDXCSxtKqDaM5qjeXZkkmUosgUcEGlub2ZyCyKcfLmmz3guAkewZIwSBzn1PtRzLWzEotWdh1tqENvpSMkUYnPD7iST9PesiLUTcXRZztlL/dJwBn0qSW1hMbSNNls4AA4BrNmtZE2Xjr+5ztVgeSR6VrGUnZGsYR1a6nTLNNbXotZQomLIeuQM5xWnHqF3a2lzH5ZDGQIyxjeDnoawItQaeMzSNvmjAILe1aGmXstnei5jYrkBtp6N7V2U3fY8+pF9ULp8KzQusc4UxiRmcNwQOf8awtburefT9Nntgn225kdjsGPl6c/571q63ZC11gy6eTElwheVHOFORk4H44/Csu8t4Lax0x4mVJEDIgYgAkcn8ela7JozcVdNv8ArUzY7H7UZrJ3W2NzLHIilcHg87W9etbVrfWmtqyQzyWstpIIFlGAzryuR3zgVl65C6X+mX6O88MpJRMfd7kZ/UVs6LDDLLLFbRRugkLyxNFznGRgjpVR7GFRXjcsQ22m3epRW0c3lSxoWWZZCgDD7rMO3f8AOs/xA91HCvliKYxlcPt68jqPY9+9W7aGy1BpLqNSsqHypFTqwIBUj+VPDE2kpW0uFEKFZSxwz84Bx3xVNXRiny7nM3dxBa3SvfIJLhQAuBgHPBz7j1rC8X6X5yytsxJGE8iZm4cdkY9j6E10M2nSTXwijb7QZeQqsQw/z1qiumy208rXkoEbMsO0ZO4HPJrPVbh5nCWMs39oeWYJG8tcNFjoT6+lYepxN/byoVClkJKkjArTuL7HirUNK1GeVkDhbeYHBAA6HsRWdq2nxQa8nmSxoxiOATncP7wPQ0JtM6W+aFnudF4Ve6trN4ofviQBCDx1/lXZxC/ZdV1U3SArCQcMq5c9Mjjj6ZrgPDVsvlnddRLkjpNtbB9vSt3T7eK7vpMzfaLWFS0i55wBnj1NLnCcep6la6paHw/DdWfh6Ke5RFEspAkVf9vJ5569Kw7bT11iAXMstnZpDg3OxwqOCxPTrkcdBWp4Tj0a8F6LR7iGxtYl3CRwzsD225G3J4zzXXtbaXbCQQWUElsiqWkIDbG64X1AA71sldHLe0jlNYW0gtntxcvLZIN8XlD/AFbgZBx6VU8N6S15Z6jd6hcvuFu0iMRlSRzknP4VNqt7dapqdwsMdjb2pG5bib5SDnkgA/ocisKWSMvFZWh/1ahZHyRucdWNKTRdOD2bLdvfT2Dm7udzz/dtjuxtGOTjtUj3EV28IbfHKfvTynJDdd3FUxZRo8Ut7KBMSQi5JA4/nWloESTXyPeReZZxMy8nG59pJx9Bj86x30O2CUVc7C21W2trZ7WMzRvIuC+flOF+8O/OTTdKu0msb4W6lI/JZVx2JwM5/GsvXrU6vcxnTf8AUuc7i/3QoGQf896saG8K+bHJj7PKQiOH4UDt/n0ptu4Rirabmg7tbWB3SLtUAEL1J9av6RdyLJHHcERo4xvJxj3qpeS2pmiCYaP7hb0x0/UU+fUI28xUUsm3HsKm6TNFHmW25Vvr0PqKmCUYYsR7j1rpdPYyWeVYkNnmuZ0i1t5rsBmLMuY1OeOfSuk0aJ4YDBNw6EiudJt3NJcq93qhsCPBG8qD5Erg72FofFczQg/ZLqNZUI7NnBFeix5WK5UnoSw/KvPNGuzLclbtTIUnYRleqjOf51dVaRR6GGk406k12t952kdr5NtiMDOO/euF+I0iwx29sxJWV1zjqB3r0VU8yEmKQAgAlWHJ+lef+MrJrnX9PjIPHzH2rLEpycUjLJ5JYhOXTU7DR3jt9Kt1HybUHXv/APXrM1C9jW6MmNwPFStHILZQcBcfnWNdEDaS2MNnHetqj6IrlXO5vqPjZJr1beNdwk+YmrkyeXZhm6ggA/4VlyTRxzB4mJfkZrQsphLEVnP3HDqCODUxtsE9bPoRatOLX7MkQAPmBiV46ipTLGG/djgkbc9az9SJuFikXsScAZ6GpLW4DhmI4xnB9R2pOWpLh7qKd2kjT3DquPn6etTWbCSQK743AkHsKOsJKtktk9e9RKmxUKgqqH5d3WsJWsaRjdWNLS5GgDrIQc8ZNFV4pA7LnnHeipTFKCbuye7s2gTJX92RjI6EVnITariVd6N/ETzXQWN2242t0BznHFUtQsERGQfMjHp6V01KalrE4oTs7SMeW4gaNsMenBIrJjnaSYqkuADwcf1qe5BtZmWUAJjGfaqPl5UmBgVZScj2NcUqb3O2KSVy9cPsuAGVXjxj2z61FPaBrUbt6orZVc8GqcUwuIsbcPHz1610VnqEM9o4njVZAvAx90+tOmru1xScoLRGPI0n2WW4Ma7oyqlQOdufvV1WlWKa3BE8L+XOi4QEZBwMiucgRpEnnJ3qCQ20dAOvFbWiXn9mXloYcNuKum3oRn/6xrtw973exx143T5dxtzNJd6bPYXK5v7JxJbzf3k7g1nXCWE+k2n9oE+YpOcAcBgDkfka3fHEcdvq4Om7mN/byDGMbGb5hz25H61yWkbJtNupJWHmx2++OI/eV1PTn1xXW9HY4fjV0UrpbttIgE7NDC7s1q7HjKnB/mK3LK5gg1XTtTS53O0YS4ijf7wC4xj9c1XtZNK1uzgGrzyQi2Z5Le3U7clwuQT2AIrG1zSXsprW8siAm5ijxPgkehFJO2qJlvyvQ6eUXUesoY1W3tmBcXMOA+0njOD9Pet/UgbW6tprkLvlj2NGHOGweqZ4yQQayIJtPuJ7WO3VriKVN8iyDDb++B3HtW8bObWbF0sY5EhVQY3Z8hCDyMHrWiOaUr6M5JY4INUvJklnsmRwYUdgSvPzA556Vn3jQ217M0iyuWUsiyc5U9D7cA/nXQ/YbeSa4uHInZCDKzk5YjsM/XNU9Tto9RZS4ZVgUgSKOvoD/LNRJPYqLV9TxrxDaRHxXYajcRH7JuCyOw4B6AEe/GKxNRuPtHiSaEMoijjOxQOIx6Cup8ciWWeItGVeIFlweDhT1/IGvP8ARGlvtej81WDzKCSe4I5P5UlojVNqdmdZpIWPzJJAoSNQC3GRx1ArotAub61nMdlbxyO7iVWZQTtA7j0waxJLSbIFtb7i8eThc5/+vXS2DYsYJwPs15CAMkEeYCfQ+n61MdL3OislKKR0n9nv9otZR5NpGrZmmlQtFLg+vP0rUvYhqF3dXHh8rY2EAWWW3kl2xb8cgA8nPPTtVywu4rfSrZhqi29lJzNE8G9Fk64x2B9vSqWryb2WS7Sz8+3bMJxk4J446MOcjNbKyRxK7lynPCe9WYxsEm8/KhVHAJ7D2qO3jvPt0SxrGv3jMxbOFHXJ9Kk82OC6ijbzpjHJzgYODycnoKl1Ca2ukjtbKN3TzGdmBw4Xsue3JNZbq5vytNxsXLSCye/ae/W4a0t03+VGfvP2yew71YsJd9h5KRh7dAzlc4O5sAYPXArJF4Jr14mYRxuFEq47DjGa2EubCG0SK03M4cl2YduwFRdHZTptpHXWd7o4t3tbW0ktpJgIi4PbHzHH1FQQWdtNb2llaDPlMzOQME9/0ArB0hSyS3cTOQpKhQDkjuK09JeYWT3awv5DuYjIo5x3xQ5XWqLjRUdn/wAOaN35Md00MR3OvzrxgL3z+VT3CJBJttkbhRvDdsis61ZV5aZY1bne47dqu2Tq8rBJCZSB26isZSNVCxasLdsq67UKfNx3IrR+1l7hipJP3h7+1ZMz/ZZmBzkjnBrT0dI3eSORiM/vI8joehqE7+6gnHTnZoXb/wCgXL5+6mSAec9K878IuZWklEeStw4K5yRXdao4g0rVDPkHylCcHBJPOD07V5Pod6I5JHbjF5t699tVUk04HbQhzYKq13R6o0jyFZLc7HXhqxJna68TNuIzBHtOPU81d0q7H2dpVJKkc5OcVy2gaorT3lwPvTzNg+wOBTpyU5Jvoc+GpOPNJdF+f9M6y5lZkJGCFGCKw5kGzdIRhm4B6itW4x5blTguvI96zW2yRhWxwMD6iib1GnpoZroGJmDc/dwTV+CRZJMISQFA+X1FU2aPzNr4AJwRTYma2uhLG2AzfIfT0qU7am26L4naNniIABHzkiqizjdIE4UpjBHv1oeYyTMJyepIP94etVYboedLnDeYMDAxiobuSo9R9k5jufnG2LkAd8e9TySZCqM9Omaz1l8sM4bcucDPcVZiInVWAIfqP61k+xolrcmtcMw6Ar6e/rRUltbncZBwh6iigqTTZ0MMBnXy8qZ0+ZXA6j0qvIdzMrZ3e9bvlASpLa9iWz6+v+NY+vrIYYJrOIyySlgVU9QOT+Nd6V1Y8OFTWzMPXNPhkQMihhjHzdjXJ2IMdyIrgExsTwOo5rpLS8F/FLGX2spwc1j39v8AZ7xWbhm4XPc1zzhze9E7YS5XyMY9slrNm2IKN83PYfSsyW5uYJpIggZHXG8HOPepHuy0zdAc9PUU0SgRygDLcYIFc7Wt0dUbpalu3wiosEj+WFZnGeeeDU2mymSXyY5Ahiy8bueDx0rPmaP7D50LPkEBtvIPsarxyXDuXhjBtycEnjFb03ymNRXTN+41KBLaKO8mf7bHOHR88EFs4P0zTvs4uPEM8qQPlLlVmj2YJY5JyPQ4rn7pzAjebB82wgFwTu57HsQKvajq4n1KBluJYpXjTy7k8F1H3Q3bI6V1qd1qeZOnbWJQ8UwTjU0lWB4YZpGVSUIAK9ga1ba1VtDkmZy8yNkfOOmOQamjmh1aN9PupGF2kilWJwFYnGT6g8c1hXkEkOsPCJspHyw7CQZGD2P/ANer2dxJuULPdGno8t0l5DPbRQQSsHaNn4XjAIHvXo13fR6b4a2wSNHGGDK6EjBP3jivMtI2XmpyJdTbLiDKnOeuOeK9FkJTwKYJdhY/MCy5B57nrj2rSBy1LXSMeDOUlICJdMG25ySD2Pr0qhqjRWcUihxFC7FskY3DH8+K6O/t7i/W1u5Ik8iOFZCqHbgHIIX26/Sue1uJLrS3cqyosuyAOdzEDucfl+FKWxMNXc8/8VQLc2KzK20hgMN6EY/rXlnhwOnicWznPlq0QI54Few6iitE+8AgnC5/h715MbY2njAuoIiZ9vAxgkHA/Q1G5ta0otnchFii3REqIyVG08jjI/XNTaebdLSORm3zucMD0zUdk0slmUSI5jbOQMFj3/SqgWP7PIkcpGWyW6ZAxikjtqyTPXvhzmIQpNOsVs8uGjkHGez59BVfxI2l3VzfW+n2weIyjFwwAY46sp7ZPQVg+HNbPlR29wWVoCGYAZDL60t1/pE0skcix22cqCwXAz3q+fSyOV0OWpzSI7mISAKpRYbdCxUdz6n34qLRNyJOcujNHujDDbkE9fpSWJj3XAJMscjKcnJLDvjt6Us3+k3rM0zhETYNzcgA8KB+NZtmsIt9BtjsjMgnRtpyMu33jnnB9MircTK9wYfLAYjgcED8ap3JRLWNZJJJSpI8pVxtGex9+tWodS+zRbYRiCUlSjLlsEg9f+Aisn5ndTX8qNySaeERSxN5cUihXbPAweuPWpdOvJ54WtrYuLUFn8r+7kYz+QrIgb7PGt6yiSP7oTHGfT34x+laWiyWqxLNKzIjnBOCdv4d6mTuaqGl0rmzB5EcYBh82UrgAnODmtO0uETfJIhjcLx6j2xWREzyqXRQueFYip4PNdsspwAcse+Kzb7A4J3uXS9xeSl2ZHdznoRXS6PDicDIMjYDHpWFpMyAB3wVzz7VtQxtcXwSA7V2lyfanRV5XM6u3LsibU7K4MVxGjW00bkboZOQce/b6ivK9X0q3gkSCyJtLo3vmPaXjj5/lP8Aqn6MO+Dg1ofEfWJ9PtwsVxIjMfl2tgmrHhuS4vfD8Sa7bw6jGfnCzpkr6YbqKKkouaXVHS8PWw+DdZy0k9tv+A/61L1vvttDujIjRLEjZDDBHFeeeFXdiqNnGcr+depa41gdEnhNwqWhTYwlchQCOiyYyMe4rJ8O+Co7O1ea3nMyFN0ZyGP044PHcVXK+fQnB4mEMPN1NHJqxcS6i8uJXPz4ww9KqtlZCAOSeKk1DSpbQJqBJ3cK69vrRdrHjKHcGAIwelKSfUiPLb3WUbqL5wWXL54z0qJcKCsgBU8gA9K0CPMhDZzz+VVwFZnzg4G4fWhGiloVZn864QBgCg25FUW2W21cgqSVz6/hUw85UCrCGl3cAGors+YEZ41DqxP0xWUl1LXYlgVGjl2LuA55H51NprgshQ8449qo2d7tvHOR6YHpjrVmzcC4fqOalvQdnsbsaEALnk9aKmhGYlJwM96KhmfMbmmXlvPZOYnDxqVYE8EDGBV3UrSOWyLRkCUxiQFONp7iuN0dfs2qywQFMyrvhDZJZx/APrzXXaPezyoUjgcW0sjLlxyxHY+nFd0ZW3PDlHqjznW7YWWqSiNHRWOGI6BvQ1PdyW+paQIpwTPEpywI/wCAn8D1rovF9gLOO4jUD7Ndx7Cx5KsDkH8681mkEaB7hmSSM4dT2xwRTvyu534WKxDUX02KixSwvIs64YMRuPWqwmZZkVg5SQ9V4yPSuuZYtX0+S3iWOVzGXgnQ8jH8L+h7iuH89tnlScSxnjPGDWNaml7yOqMpJuMy/cTvAVihUpGDlh2+tOtb9TtjWQAuecUttPDd2oRsebGMnPU1Tggt7h7uTzjbyxoZIQq8MwPQ+nFRG+yFJ33Op1CeJrF4Z5JG8tg4CfdLYx9eaqX0lrc6DY/ZUcS2mcgDnYx6n6Gq+jxtfAwXkoiQL/rMFhkdPzNX7SNFjLh1F5Ce3G5DwR7j2rqhK6PPqU0tY9ChfxXMOoK99G0NzbYkUAbd8R/uHvjP4Vm6gJbj7RLCrIE+bY5yWB710N4lxPBElzH59umJIJIj80IP3lwe3HSsG4KQXYkjSSGcSgoW+6QO2K1sYxbk+VGpoCx3Or28oBmvmQtI38Mnpn+tek/D7Vo/EGnz6bqkKRTr5iiLIzgYwTnp16/WvNdIddK8VtfRK32B5iMgD5dwyRj2zivTfD32CCa/hISS9uU8xHXqwAPT8hxWkGY1IK2i/wCASJFDbWYsVaNnEjbWBB2g9VJ+tY93Y/ZNNMkkxZxuLL2X0rL8RXd4ZwYUKMW+6y7CeB/9arEjSz2FsCjqs4Dktnkjr/Ks3UTk49jo+pyjFVG9zjdTtyBbq53I7O/5gV5R4tV7bxHZOi/KZACfXHT+Zr2bXI2lZFdyzr8ucfw5rgPiXZsNJ+0xLhrd1dmA7ZwamPUVSKWrLIDXB2xqxLDLKByRjrTodPi+xEwgyMjYwfulSMfXINM0O4WWwhMg3BkIVlODz71ryWr2rO8yHy50ABDYXoMH8Ke+p1yhG1r+hW0xnsZ/38YmiDIHAPIB54NdLeQQX0kwttPa3slOwtKSCQOSTXOLE3nJHjbt5dhyCvY4roLS9uP7HbzZvMlGQigZ+Wh6GPK57GdfXsUXm/ZIwFIG3bztH9KuQQW/2RDJNm4BLyK3v/8AqFZKIosGAG19xLH1yacSq26PMgl+QYUZ/Ws2rmkE6b5bajXuJ4dr8uobbkck0Wcz5DyISC20gnHfpir+nTN9mBiUwSRMAGYZxUMKXTXsUZG6IEZb73ShxNqc2r86NSaVLe4gtFcCKEbth7FuT+OAo/CtceS8QVl4PIwOp7Vz8s0z3BjiiEmZC2SB1+ta2nTO2ySbAxwB6AVmzojJcqRvRMQyR4wR0HSrJk/d3AjU7doyp561lNqFtLeRiFMsow2T+tSXV4qqSpAI9OtZystUQk5NGxp0WIgeAoGcVqHVYNI0W8v8hpmzEvHC+3865Gwv2Ns3lljH1JPGTXO+Ntaf7BbabDJkNIZWUd3PApU6ihBzO3D4KWKqqm9r6+hmRTXHibxQgYb4VkBIPSvb7eygttMUEgcfN2AFebeBNDNosTvnz3b6ZJr0vxPGll4caynvRJcO3yInA2kZPP1qaSdnOW5tnU416kKFJ+6tP+CecePrhjbPZQNuhPzZU5yK7P4VQLd+H5TKDhGC7zx+Veca7a/Z9OMMe95ZWGATnA9M16X4aW6sLLTrDywkdpFmTB6yNySf5YrbDRtJyZGOpKjgVSj3/Lr+hsa3LHbQXVhdFXDJ8suOcEVwMb5jjxztO049K6nxjICqMOdwyCOtcpBH5bIw6dxV1Xd2PMwsFGnzdxHkYiSFMqScqAahuZAsSxAjcT3qS8yWQ9COtUZFFxK4LYGM7j1BrG3Q6YrqJb3KWxJIbJOKiv0eYKqYyTz60rhlcLMowejVKkeI2G7588GpaurFtJe8jOhtnWRNy/Mo9O3vW1CiJJGwOQB3qrYs0zyeY4EiA8+tMhmHnlc5CnpWUtEJNs6ETr5e5TwOMUVQtmLF0bAYDI+lFQ0x2j1Eu/NaIS2jNHcRHcjKcFT6iuj8IavLcTpaT/MbgZUqSSrj7x+vBNc+GYsx+8QO3pVGKcwXziN2iZiHBXgoR1I/Cuvma1R4zinoek6sJdSs1ilQeUfmV2HJHb8a861Gxt7PXYv7QHmWMxUSMB0Xpn+n4V39jfNe6BA0LBZLf93zySvfg1zWtW0jxibbuEeflP8AEh6itOZXT7ipOUH7uljhF0q40jXntIrmNN5LWk+7EU4B4Uk9/SmeJzDqWnRXVvarFexFvNfONwH8OPUHvXTahFaahp/2C6aRrGRGa2cjmKT1H9RWRoumyWuj39vfgOUUPHJtyJRnpnucGtLJOy2Z60prFU1Ub95W/r/NHH6bPHJC0o3i5UEMCPlx2x+tWQ2YmO0MG6Be1UtVRbabz7YlIydkqH+A+4q34f8APuAiuuHD5wPSueUOV2M9YuzLFpOYX2iQrETuAPY1sSXa3NkJVKgiQGT1bsBWddx4m8pkCuDnJ71FaqkiFdwUq2c57VcdNDKfdHUafci6tPs+mWommlJRbdmyWfHGOa5K/mbzUhkgmjlhI3q4wUOORj0zU8jtZ3YS0kIwwZWzyPeop5w2qmS4Vpp3J80MThv9r9a2UrrU4ZQtK6L6AyWUUoJbLEsuOB6V6F4JEFz5MpKpfwtsjYdWH+RXnmlzSQIIpIh5LEAP3Brd0m9bSbmN1QrIrFwz/dYdwauLW5rOlJK3c0vidpl8y3bz3AfYM/IOhIB/oK1PDzNdeCrCdxIrK7KSenIHH6nitG9f+2mk867iIkVQpjHyFiOmT3qnpFy+n6Zd6ZLEbq3RzL5rLt2McDHpUqm41Oboy3W56Hs+qscrq8aefy3yY6juK5jVYotR02/tsgq6bdh7g9/0FdBqLO7TKmdwbGO4Fc9KAkkqZIZ+eRQmYShpqcP4CmEkMUN1L5cUTsgCjJGOK9L1jT5INMghbo8YlTceo5GQfTOa8o0RBb6vqFkx8uZJiwB4yDXpiyXraVHJMy+VCu0Bz0U//Xp97m8Veknf1MzR3tLO9ntLp3dwqlJQDlM8kfh+tdLaJFC2+3v42aY/IUjJZgf5H1rkNUiWK5Q53GQglgCNoHAX+td54W1BdNjclhcb42SJwnIDYzjPTvUwfRkTi/igZDLG+I/LKkHBMgxjGSWNU7e9jnjmIhcQMxVO2QOP51d1eUrLkHerkgBj19c1irHICzRlhEg3soHXnp7daZDfv3RqwT7xBGpMaE5dgA3fg1JLLLavceTKf3QxG7DGR6Adqz9PkYO7iIIsSnIzyxJ4H5/oKcZMTFroo8jsFUI3yjioa6nSqnu8rRLE0scEsksodpFyTjuetbGnxhLWMuo5OST27VjRh2lmCIDsIAB6Zz1rdhs5xFE0e6SIR73CDpz3qWjZyUtSedA6bhIqsP4VHJX1pUJklRWHDDBNI7Ga5QRR4eRggHQZPQZq9Zo8l64uEVHjJXA6cfzrCpG5rBpInvlWKyVBtU7dxPoK828z7Zr4MfzKh69Rx0rvPEdw0FpPNuABG3Pr7ViaDoU0Onx6gFQS3LAhWOAFFFWF0oo9jL60aFKU5PfRHW6S7RQRG6WR+NxC8HHtWf8A8JBHNeMs0jtDGdqF+ce1aun3EX29Y2kVi67SB/Ca5PxVZTWurxxwQAQyc7gvU1NrK6Kwip1KjhNWbV0dL4csE1vULvUpv+Pe3OyEE4Dv6Ad8V6jBpotLAQsGd5P3jsRhgccg1x3gyGHS1toyFOSGIbua9Jd/OiMhhyg5bHpXfTjyxPns2xTqVeWPwrY8w1hj86XAOFJVT61jlt7oCMAj8q6PxsqQ3gEUwmimHmBRxtI/nWFHEZEdimAMFfSsHH3rDpSTgmZesK0LIwJx0IqtZrhSznO725rQ16IratMpJwOVrItbkKELkeWT94evas56SN4O8SwUfK+byAeBVeU7OMkZ5461JLMzl2UgjPHrUG/Mbbwd3YUFq/UFLF5G2/MB1FMnfa0U2cNJw4PrU0TiM84+b1/lVO7AkCgDjPTNZNDh8RrWUwFynnYIIyOaKzrUFnQv90dvSiocnFlygmbSn/VyliCwx9PaoL2LaVuGXcc5x04qzJiSEqRtJ/n61DJJutVjlOHU4/Gt0eE9di9oF80N6jCTaB8319a09Ua5FwnyA28obYDxjPODXJ2d5FBfRRTII1+6HAyDz1+vaurvL03KSBhulBADg5/P0pJWTTLi+Zp2OftXhe+FhqLGO1mbhx/yyf1/xqvrNrfaNIqPIz6XLJxIOFc/0OM1JrUMsbKSnMgDZz0NSQF9WsDbXLAJuypLcBwMcj+tbU6n2GaNyoy9pHZ7o57xHo8UwWWwGFIwy4z+J9a5/RJZILqSBj+8UZBA4JA6f0roHMti0iSsyxg7Tjv2rP8AEdsLcwX9oSsXCybeMj1/A1pJcxt7TnSbdyvNfPezrI6kSjgjoTUdu4t50lKgg/KysMg+xqIMtw7vEwVux9/amQO8u5QodyOQTjB9RULzFJkhkMqnyomDg9uflrUaNbqASnfHf28JxhchwvYj156+1ZJ2pCSC4kJKkjptqQyXMtvFdja3IiZgcEHHGauPmctVdUTxXMjwiJTkEbtpPVvUV1lpqkb2kSznLKQQdvG761yljHJLYPGYF+0JKcyD7w7Y9Mc1fspZv7PlB+Zk/dtHjpznP50R906Kk/aQSaPQNPiuSBZWM0UaSfxEAgKeuPQ1k3c9xZzTwWs0k0Gcu0nTj0xWhYXijw+kzASTREK0f97jiub1acGQhS8byMNigdTnn2ArWWxyRTUncc+mSTxTXEknlhBuVccyGsa+iEyh1Ub1bJIPOBWpqdxKkyQQEiNU9c4rJeSYsElUY253AYyBWCTT1OtvmR534hjVPGu8oVWaANu7Eg4P5cV6Hpb3UFhskZZbS5TyXCNg89MiuP8AFkQMmmXKD5llMbEcfKQf/rV1umwKdMJkl3TQAbdp5OemPWtV3IhC8LeZGbVZ5I7HzlGG2/N2H1q/oU1ml1JaX6SRyR8nHTaPTt0plzph2xXFo4kaQc7vlMbA8g9jmq8srMkcE6Mk6ucKRjrxmotbUc1G6s/UuaoLO9vGltmlNoAWRZeGXPQHFZlnIWLgqWc/KFH8RHWtS/RCipEV8oD5nzgED8M1kW4UsZo0wrSeWmOMgcZNPW+pnJq9olz7CqoN8ohDuc/xHOOP50Q2m0OZMSQq4VSTznHXHpU9xD55/d5MS5LkcZOeeafFNFZypJBAMRsNyud289enpRYmLaR3fgzwdbxXTXF00d5BdRAoAGUR59TWVqstro+pXdvYbZ9jYJZtyqPQY+9j3rM1zxXq+o4tpDJY2jADyozgAY65H8qy7GCS6RYraW3ijQ5zI20vmh66IzoQqX56stGb2oaxZajZlrnzVvkbHm7QEI+gqXR7W9aMsF3oRwyHPFc9FZyvKiqqbQfmPY+9dDqdzHp2nJ9n3GYgKqr1Y1hfmep6dKly2jDqYnjO7e4lGmwK2VG5yRgD3NYGmy3Ms0kks0rxxgKhJ4x7CvS9JglstHJ1RmuZpRkrJhse3NK9vpP2MLJpcal/+eLFCKmpBzd7npYfMYUo+zULruvxepxsV2kEUVxO7R/MPmHr2FeoRWAu7SO4mAACBgcVyenaH4W1zUfsMtxfRyxneYSRtfHbcK9D1F4YrBLSEbUACj6U6KaMMzxScoRgmpdbrp5HOyBPJDSNglsqfQV1+m6hK2lqsbkyqPl5++vp9a4PUleIhHPy1Yt9SEO2MMc8cg1qp8rdzhr0vaRXcueIN818obaI513oR0B6Eexqe1t1XSJIHyZUbI+ntWZfzZ+eQgFSCuKpXOp3FvEJYwX2kEr346URkubUxUZOKSF1OEvbyISM44rjrSXZeNC/TtntW6usNdwh2Ro5ATlWHvWff2ceDNE2XY7j7Gsqlr6HZSvG6kRkbCRkE1YWPzguCSQO1UEkJfB6sME+9XIJAOE7HDfWs4vUqona5VnlZYpBjpxn3qifOktmkCZKHPFad2EKsT0NS+HplhtJomjEjjJVv89q2jFN2Zm5tK6KNpKs0KlWKsTyjcUVHJIv2uQDapPzYP8AIUVjOGp0QbaOghbci7sFTxn19Cf61G7KHtmkbCO3ltkfdbtVy6T5AUIw/wAyn0Y9voaonFzaSwgqWHUMcEEcqfxxj6irSPFk7akVxbqL9Ay5jU5Ptnv+da2mOtqXikf5H+Yk859jVSFhdx9MBlHJ7eo/A1WiuXaRxIoYwvsUqPbiqfw3FSfvWOjvpbSe1kMfA4RR0688fSuSjBsr8OzFQ7AHJ/WumsplYfaJkUhCA6r8p2Z5I7VS8WWto0KS2AzBgAf3gevNQ19o6018Hcz77zP7R2yqksbptGV4I9/8ao6naSm1SCQF7WVSI/8AA+4rVtpVl02Qync0fT1xWfdXJhQLNkWsnVh/A3Zv8a6YSTOSfNTd4rY41oBp12bOTJwoZWpGYRnYgwynNbes2kmoWcweP/TLf5o8dx7eoIrntLnZ5EdiCynDAjpRJcr0NoTU43Zq2MUMo23EzRxY3MyruyfT86LqIwKHQjy5eWUDGPrU94VTy5LZRslHIzxkdR/n0pguhCFinVDDOucZyQM4PHY+n4VS0JlsVdOkKwTrG580HdtHfnFaaT/M5DfOcFjjHPcYrCkhETho5ACjYBP3m+oq1p826682RuC3zd8gUtUzWK92zOu0S8IluWCiRFO8KTgCr1pOmr/a5/sbRfZmDtJjjA7D61j6TdAz+ZHbF4VJEkQOFC9ufzq7qmq3GqBrLS7aOOAjqhPzcDn34FWpEVKSW/39ihLeSTtK2393JkLx1OetJcRRpdSOAdnlmNRjgHgniq16Hi+z27TBiAATjGAOwp4kaSJiCzNuLD19M/pWTeti0kkmjmfGKB9OtFgXrMvbnrVnQbyWLUUtLgDGz0xVjxFA0uksFxvHzA+hFZejy/a4RMzn7Q2G3NzyKptW8yqMm5O2x6BcWQmj+XfC+3fww2uP8apXPkiWKRbgvfIQPLkQMhHr0qeyuobuBIZ7lIRjAZh0NJNpVk8buuqwySg4KbSN49QccVS7ozrQWzMthc34xMAqplAFGAB9PSmWKH7ZCJAVt7YFMgdWPr+db0+nIsDSxKmxOAquT+JJqHTURyqNGrPJIMAnA+tJRMa04u3KVZXnV2Z0EdqThAnt1/8A11AES5bbFH5irwCDg5xxVnWJ0NzIJ5lyAEGwcbaoXV0pUWtnblJAcgqpDgUnuVF2ikkQ6fdXUt8LGOdMxybgclhnGK0prCO18iQ3wlaUZljhU5jHoabpei3M1i9xayQRiMEmRztIx1/GiFpAk0LuCGILMOdxHo3pSei1Lp/F7poWDeZIEZT5CDIbPH0qbw5v1nX3kC5t7c7EJ6Z7msq6vDZ6XJHb/wCsb5V+p4Fdj4Ws20bSUZsbyuTnuTWC1Z2Vp+ypPu9F+pd8SKdsUMHJJGT7Vha9fG1SVYMFlXaD6E1dv5pCQX6ucjHauc0x/t+pzwOck/d4zzVSd9O5tl1LmXM9VHVlz4e6T5l011Ju84tuLHsa9OmWKSPfK21l4Brn9JtmsrTaPvYoYzwsWcllraMFTikLGzeKrOd/QZrFu0imQEFBxmuSgnA1NYp3Kxk4FdLJOrgKwOO9Yd9b2xvUaXAj3AEjqPesppMT9xcrL0oVpm3OXUd/5VXjLPJIdwx2B9KlCG2vmjLBojjax4yKkaIC4+Rcgdqmzi7HMpFJ4lWLfhd+c4x2qozGRHwRjuD6VrXMDsmUxuPas24hZAokwOxxUtm1NprQx5Ij/C3fr70trg5JYbgea0ZLZesfHHIPrVHYrSbVUhs4OO9RszbmurCl/NWRWxuHAHrVG08yCVxuxhuB7HtWmsSkbuhXjmkktVnADHDY4YHFaMxukZtxGzvuRSSKKn8qW0cEfvYumR1FFZS1ep1Qdlobsc0fkSRbwQuCM9cdqp3FwIZVm8lnGNjKB1otBDcW9lexLut5TtJHoTUxy8GowbyZoX+Xb/CMZBrqjC6PEnYiSbyZwUc+XIeB6HuP5Gop0iXUra5jnZIt+JSPTHU1lYbyhOpYSB8Mv4cflyPoasTvHPbKqnbKRuIGfmX/ABFRcygnF6HZ2cIaSRUw237p6giqEo+SZByvXB7D2rI0bUZoYEjYtmL5Sw6lexrVvZBJAJEGMDHB5/KobudUE0zFZ3hnKknGT24NWr6KKe22IpIZMqG5z60xppZVC7QGAOFxVK9n8vDqBlBg4OPrmlGVjaULmZFfNa7YpTjYcI+eQP7p9q57XIjY3y31u/8Aok5wwH8LVu36LM6JIvyOOCD1FQaXYPeF9NIWQSZUBzjJ9veuqD5lys5Jr2XvLYox3AmtShwCOcZ6j2p0M6PFgovm/dDkcn6VSuLGbR72a0uSwePGD6g9KSNRJzEjOVG9eelFnsDkpe9HY272JFs2kUgsCM5PIz0rGQyJOYyTsPzAYqeSUTKiqpyyhid3GR1/Cic79rHghgM9sUMuMr6s6bw+sEscwLiKWRQqknjPTmta4tVtdTW3QmWYJtwhC5J/kK46waVmQbSqhhuI4xXZrMkQe4I3s67cnnn1oi0y6kLO72MlrOSS8ke6KbVYZCncCfrUkhCZ2N8obAAHXqaSRJr2QOZCcnKqBhV4xmp9tuLh7eOTf5cYA77e3OPrQkmRd7FC8tzcaZKzEjnj6elcToJlSS++0PHGlvIw8st85Gf4R3r0uewxYKGb7wB4rzSaNrHxM3mEbJRn5hkE5/nT5e4oTaeh0/2VbpQIbgb2HQnH407T4opX+y751kQ8sBkE/wCFLbbiS92m6I9DGcMB6irgaDTrZbmBi8m443Dlh2z2pNJM6FNy9yPUsx218YWVhcJbtnDuuAfU/wD1qtzMI4AfvSEBC3QAUlzrd9qKNJc3IaMgEovAT2x61nm5adGkCZtE7YPzH61Sa6HHWpTg1zldpbc6jGkw8xAxJbuTjgewzW9o1rdRtIt3OsNoRukdFDNHnoMn+lUNItbNbJruUPNcFiNqD7ordsrtE8PubsMMkGFFVTn/AHu9NWWrM1ebsjMZbW5nkhLyw24z9zJ3HHX2zVQAJbxxrJmbJyv90ZqzLPdmJ5TA0KnjJ6ke9Zd3drGS0C7pMcnPesZNNXPSpUnGSTHK6XWuWtqPuxHzHx613JSWWF5pDiFBhVPesDwHonmz/b7pSWkOSPbvWn451yAXwsNJiYA/KFHJHuahKy5mKtfFV1QpK9v6ZU1PUcRrBAmZDw3fArT8HadKrPJJAF98YNWfDuhR7bZ5VLFh82eDmu3tTb2pZpfujoTWsKdvekd068KFL2FJX7szZkMQXcuAehPemySCZCGC8D0qC8umuJ93zeWDwOwpsVs1zEwt23P/AB8/dFU5XZySSiryMmfZLnYMEHBNcz4hiaIxvFkgHmukkSRVlVAOOB71zuryStBjbggdPeuaW2ps3fYimuGS2R5JMqhGc9cVu6TcpM+5GBBTKtnrXM3d/aT6a0ZGJW4b61f0gPZ2yKzDYQNook0noc3LdWZtMSk+452sMVVlBaUDGRnmrltL55CqABjvRNjaUxjjrUXuUtGZdxsifB5B546VRuIHkZZ4M5HQCrVypQlZgcdQaapAh+Rs7+cijc3KkczFyH6nrkYpzgzREp1AyKSVl3EbQBn1qK4KrEDDIRIWwNv8zVrzM5LUlRiArKBzwd1FQ2rlF27hInQkdfxFFVoyk+5L4IVdJbxDol0DNHbSLParn+BjkY+n9KpTX8unfFCaM/8AHjqFvhQ3AyP5VZ1V20+/0rUSuIWb7Hclechj8hNaes6ZBetbymMR9xk/d7f4Vre8bLdHBSqRUrz2at/X5mZqKmKKRgu2QsNy46+hH0rHQy29wplj+Y/OB6DkEVs6nKo0yGNMm4hZkYn0rIvHLXNtdSD5JE8tsdBnv+dYzdmTy3bsXtPfyNWVDkQzRZH4VqM2TsL56jI6isDU/NFhDNExWSBgDj09Kslp5AtwCSSAB71L8i6bNjzlE3JJcDG7FUdQ0/7Qsrbvvc496epYEqwzIFIYZ7VbtiHQgtudcbkx19xScbs6VtdHO3kDwxK4G6WIh1TvjuKz2bzZZJYyY2ceZHjgqwroLpohcGSXcWAIBB/nWLNAIbclOu7K81rzdSalp27lDVvP8QRTvkJq8ADjAx5oHUVh6XdtKE25jlBIZSMEHuK3tQdrCW21O3zuUfMuOfesTxBbbJV1fTEZrNwJJtv8Bz1rdPmV+qPOcfYy5fsv8GXbdQOdzeZGDlf7wpY1DJIDgRhgeucZ6CqAuHZYbhD97oR/EK1ILmKSCVnCITjcAOOD1qXudMLJM1dD1QxiVDbxyK42lZOP+BVt6TCZJx5zMVbnyFxhvxrjYpCJVdeQBjjv6Guh0+7dYyYnKN/ePpipSs7m8p/u2mdPqd8fslwixpBFGFQlcFiAMY4/OuXtSUuCYULEjDMf71TG9hsLZGliM1xcA53tnGeBx61DbTNZwb05kXjp1P8A+s05JymmKjUjRoyXVmpZXUk6EPj5Pl56VzHiizG2O4ZSdjjkDpk1u2YntYn84DzZHLcHjJGMfnVDXDP/AGXKJFRjKrL7CrbsccG56oZo4S63Qum5x93P9K2hb3MYMMlhC6N90tjOPUGuZ8LXCeXFl3SUrgY5B9a6mPUFihaO4bzR2XGDn0Jp6PU6G5X0InsJWuUAtkVWPKo24nHXJpFH2qZrUusMEXOF6Gtd7mKRCtuY1O3DFT92sy0RmZI4XVLdW3FzyXNDOapdy1LqXCQ28TW+RJwI1Ucc+tLqF95T27OkTywvuLjkN7VGkKz6XunmYRlzkxjkiqjPGqeXbxhRJ93jkD3ob0Lox5ZXNfW/ENndaWotU33DuXddm1UOPWuOsYTd3nkxZz2z2z3q1f7bYrHEQWPQenuafpEsUPn3bsEdfwx9Kzk+rOuK9nF8m/Q7WbVIPD+kLbKQ9ztwNves3whYPLLJf3a/v5myN3VRWNoFrJrF39ruQTGrfIPau0mIiCopwcdBUR/nfyO6FGOEg6f25bv9DehZIsorruHcGmXUjTjylOR7Vg2kqrIzSOQB2pGvWeZERsEnr6VbqXRkodUaV/di0sxDGP3pOS3X8KqaZ4hNjI5WBC7/ACsx6EfSsq+uEjZhIzEntnqahEbtHGzNn2PpWLm73QnThJcsupsC7hlZmQFWbJOenPpWNcuirJvBLE4U1YYH7QkaoRuIUDjNGtpFYXa2kskbyleinO0+mamTe7C0U1FdTmvsXm3GXQKoPX61oQRs0qo3CR8Kc9amktg8OF5kLBsZ6VKgZVIVs4GM+9Y7DepYuZxawh06gfNzUP2qV0V2UBMdar3QYL+8HzY+6eM0lvcJJYiUELjKbSf5iqhG7dybWLV5K1wux8YI496op8g+9wOx7Uiyb/uZGRnPpTZvnTK/M3ekpXZoo6EN2c5kGCFHK+3qKy43xKrRTbSpOA3Bwfb0q7cnEShsgHhj2+lVpoLcW7BmDHPyEjtWqVyJJofayK0redEUk3bdy9M/4UVNptrJC28udnTDdKKVmHtUtCae2kvdJvrCQhWkBWMn++pyppnhnWn1jSFM3FxbgxyKpwUIJFapRis+fvMd2Pcelcp4eI0zxxcxXIC2mpxMM/3JBz+ZrZeR5NJ6tP5Gs0f2m/ZQpUzxupHXDgDpVaRw2hLbEbpk3MCeo5/xzVhrqKDV7ZkwWO5cH++P8RVQkf2lcrkIB8w+jVk9WddrWM9Jz5G2Vj5U646/xCpNGnniseGyyEgqTnGOKzppDGk8Eihhu3qWHQ9f1qxG8aajMVO2KRFlAz19aizWoR3sblvcNLcKNuxsfePQ1csVkLgs3TOahg2lEZz1GVHqP8aehPCrnaSeTTU76m8ezIrtEJc43Mp4x0xmq08KTLKEIMRGcf3fWtKaOMgrH8zkZyT371mL+5lIGQSN2T+WKaTuNrmfu7mE6vAwimJIPAz0IrGVorW5ezu2b+z5mG7acbea6nWbNbm3JRtrpzXJalGZYg5XOBggd8VrTk09DnqxVWLTKd3GdLnktA5eEPuhY/xDrWnpM0SvvkTcjjGw8gZ7Gs8D+0LOKIP+9h7HqQOgpqXMMYBAbazEAk4JHuK6Jrqjjoy15Jbm4GaNysbIygfKB6VoWQlMG5QSznjHP6VhJMZNhcCM4xu9vStqzuLpURBsbYMAx1EdTok+V2NKSF7SEbgst3IQFLDJT3HbPalsIwXAnb5Q+4le2OaQzOIC7FmmA/D6U2CSSKyO0hnb5mA6Z5p21M5yvGxahvWxGGDsPmZi31OMVDIqS2PloxJ2lmL/AK0Ws5iiZWVSvl5J7g+lTWjRtE5THzZXmmKOmi2MHwldRPJEZHjZo+Bu+tehGCznAgnsoNzEOJkY5ryHSCPt13b7tvlXDKOOnPavQtJae3IF1G8r8cHnA7GhNm0vfNyTTIWRWS3aCM5A3E8kdTWbfSIlokNuRJO7EBY05zV7V7nUJLSEcqgBKZqpp92NGQTR+XNqEgADuM+WD6Cm2jFpppvVkLi9s7bZOggMeFwwyxP0qrdzupVpgYyAcU+6vHN1Kbmd5JmO4k9Cax7iZ5pTvJEeeXY1PoapuOsipqkwtEEzPkyjAJ5Ofarmh6fJqiJCpfys5Zm7iqmgW1trWsslwjtawcK27qe9el21pbWaRi3I244rJrmd3sexh3GhFNr3915FnTLWGxtUhhGMcCodQm8p2Z+ZPas++1doH8qHBkY9fSqEt8FD+Y2+Q1E6itYjlblzS6lyO8J8wOQpA5Bqk2pLnbC25s8kVno8kyuzxncOrE449qv6Tpw2MVUM2MjcelZxk2E2kTOJbmPk5c9c8YqaOU7AspztwM9aqTTvbo0jESOCQR7Ulv8A6WUKKVzyT3NN6kcskr9DUifc25XIzxwOtUrmEC6MjksexqSzKl+AeDVgvEGKlhv64qGr7gnYqiUeflQxYjk56U+OXykxjO89fSmyhlZ3duCcKBSj5oBk53dPapY1qRuztOTJkjtWeI900i5IJOfStglA4H3jjrWa8T+Y7YIXoD1NS9R6Eu9Vwqg7j19KhkkER3kfKxwT6VJawRtcqXf5SMEk96bfQfu2EWDxtI6/5NNaLmHFqLsUZFLPhTuA+9mo7S3lDGMlWycoG/xqewQ7T52Ay/KQakspVXVYxKPkGRgHpnpW0GpWFVV72NOSSS2tTBPAyiTGG7fnRWwkPnHavzxDnae3rRXVy2OJzcHZGLds8Ch0YkxMC3Hboa5vX1klkWOAYlgkEsb+meRXZXZXyJiMBT6+lYOqQxyQI8W3zlXBx0YDmuWEzhnFrXsZsreY1rNKDujn3MR2yP8A69TPGZr9UikKM0TKGPcDkD8KzWuHubq7iLkBUV4vcf8A66fbO81vBOxOYz8xB/A1e0rHWnzU+ZmlLYRC3NxKu6OWPDFh3A/xrn4REssMYGTDIU5PVW6V1GkX0c+kxrdA7txUA9yDj+VcxqMRW9mYDAzkAdsf/qqqtnHQUHZ8vVGzZySqXTYWEZyMdfetiEExr5h2k1mJdGJYp4hzt+uRjmnC+3Dyg23HzqPUVxQlys7GuZaF2SEkI4bDZyTms24c73hlfY4bKk+npW1bkvbEFwXB4HtWdqkRdy0qqHKg8fyroi9LoFpr1K6ATggOMA/Lnr+NYtzaxiaRB8rHkr2DDuPY1s2yAS74xwen1pt/bhwk8ZHmKRkf41Sdnc55XT1PPrxTpeuxXCZMJcM6j071e8T2kEbG4sjnTZiZUYjJBx0zW3rOnJd2zOU25BZcc1ytvcvZAWk6+ZZSDlTzt9xXTTmnozkr0nfmiT2colthGzBiDjP9361sWojtVzHlJmHQ8hq5TyzZ6rujYG3mO0Z/rW9G0gGADgDgnnFFrOwKXMtTpNPviuXZAZwCAW6Envj1FVGmZyQ6FIScJgdcdf60uk3Vulvs8sPKTjn1JpjTtA8lpIQzk7RjnGTk4oaJdlJpF9pIlgSOJS0sx+ZiOgq3DAgYLG2w5rPn8628qSRCmCEywxxT7WWSSRigycfLk0Mqm77HGySfYfFeowjcwkff5hHGD6V6L4YvpYLaQeYNzgff5ytcN4rSOx1azun6A+XIRyDnp+tdVaSQGKMeZgEfME9KFob0kpe6zoLvU3JAeTcQNsY7Cq1hKjTt8pcj70hHAPpUlgIGtnu0Zv3YIVTjms6K8nVrgQgLEvzNxzmm31IlB6raxNfSxQbvPjCMe46muU1e/a5j8i0UhGOAT1NX7mRZszXBLFckg9az9GR9VvmvQm23gOEXtkVN7lwheSudT4dsYNMsYixIc9frW3JdxSgrHJwv3jmuWuNQaQsIh85+X6U2JXWEZbBJ3YJ6msG7vQ9Z67vU1HLSzyvyqdiat28trsPlR+YVAxk96pxWztC/muVLe/aobaN0Y/ZnU5+8jVk0+hEmm9XsWgtxe3GXKwwgfKo71pQ3MxLRx7V2DaW7Ee1ZKBmxI0hCbiAuf1q786yqEIMWOfrRFWE1dCiNIw7SMWI5x1yaIJGJb/lmXPQD9BUqsxjdHGCxzkdTSRwKCpXcVHPXODTBppal23tzHCzMuBnOQetMmUbt7Al2xyKHnaTZE7YUHiieVfK2g/P3B7UXXQyV7jJF7Fsg9PWq29wybD8rcAelToCIt3pzz3qOEB8pIpz29qzbvubRskW1AjJeQc4wPxqB3IKxlCwY8kdqsuAo5GSBxzVKZmhlIJIYjBHtUr3SUrlGH93JLljnfwvtVkbmYhF4zn60rwoWV88uMUulko8iNyqHG73pxinowl5GbcgfNJv5VsEVOlsXYSoCc/MSnb8KlLwyyFCi5LEE/Wp7c/ZlfarJngdx+VVBJM1bvEmh1C53BjIpYcZAwfxFFNti8khLqrcZBHWitOeXcwcI9i5qK+ZY7RyeQfcVgWrtPp0M2wJ5R5HcjpXT2Iaa7MUgAGQv51WksYhpN9CPkMZPPc81CXU81SVnFnAoEh1CHdERtnEW4nsT3rpbCxhjtdXtXVUMsu9MdQDjp+tZetWaPauY8eZuAH+92NauiyRXfmSgtkqrqScgD0/MVpGTWooSbVjnrCSeO2uQg3SQylgSPTvU2oSpujmOMyAEirdkDFqTqVzE8rI4+vI/nUmpWHmadMVQI1s/A74qmrrQ6oxTXMyvphAVR1VD09B0qZrIvu2ZWSMlk91pdBCzRyBsKXjO0d8ipbmR0hWYo20cdK43GyudDeuhLZyi3OZgPlULycZFJNcxzOI0IdTyceoqnqGWgTeTtQ7W/wB00QJHHHIySYbIwvrVQm0LlT1J7kr9pRV43AEEDHNTFRsZmAIZeQO9ULuVo13B8nA4HOavWzRzWxYEK2NxrZSTZlWjpcge0aazkjjwsiHdj1Fc5e2KyxBwiK8XyjPQg811kMZhu45PMyh6j696raxYxiWRtpO0gj/dPUVsnbYwbWzPPJbU/vYmK4YcbuxPcVWsJ3i8y3kb5weuetdXcaSjzTIR855UisnUdKiFk13HlZFPze+OD/jWyfMrGE48j5ujFtpVjkWVzhc52+ldBZx28Wb7zRJJIBtQ9UPtXL2Kxr5bzMTG/f8AwrWjMIuhNEMYGBjoB2qU7FSgpPQ2dbvpL3TLezIwqcqAOc5OWP51Wt2SGBYw5Mp4yO9TnEsO/eCSMk46Cq0I8xWYkBR39at+9qZx9x2Kfim1F7osyZVZFIYEnpjmoPCN4k9mEkmWZCcDb1Bq9ex/6HOpBYFCCcdM1574QuJLO5mhRXLI+MD+dCdkVFfvNep659rC6dIgAVQ3ANYTlZpid+9m9OgqSO4RoWa83A9uMVVkIw8kDBExge9Q9TqlFxTbI9Xnyot7YsXlwm481clnGlWkdjaugwMu2O9c+tyr6khyP3Y7HoasRRveTkuSVDZJ/vH0qZysrIujDmlfojY0uR4opXZcs33CfX1rZgCfZGN0OAMg981nQ4MqeZwR2x0FXok+0maTeFhXgc9TWPkjq01H29w08iPPwnRR601m8y4EiH92uBwe1VLRGe6ZGY+UM9a2LO3XhY0wc9zSRUkoq4iTedI7+Wvlr2FXrRftcBCfKSeTTRZIpYoT8/c1cSF0O2M7QB19KTYKSSshBEYoiu7c/T8adaRFCQwAz1FSRYicCRgdvc0/70oI49MVHNZg23cgcCNty4IJGd3eoWIZi5xk+nQVZvYssGifCng55FVl+5sALHONx4pXuC2Hk7UXaCSOeanhRnZnVT07HrUUscixBNw29cCp7FnUBcgBepp2s9TNy0FmLtKRjA96iuYhIUy+SvApL2QysNp+cnJHrio4z5iKcFSeoqXqx7IrpKInBkTCnOCPWpIHwkhRBsl4P1qC8jcyKCAURvlz1q3GUyVQfLjP0NVHyB2K5gMcuAvA54NW7dRO5TdtIPGeDVqBQ7ZZcDB59ams7MZ3beBz1oSaKc1bUc2n7FSYEZHpwaKsQXBtpX35MeOR14orpUYy12OaVSd9rkOmEzXbSlSDjIH0qrNKfs17kA73JFLp0rrduinAUGi0RXspN4zlj/OuVS0scLRz7Q/aLtTtUYOSq1F4atvs13ewtyUmZdpOAAeVFWr6NbfUU8vjecmoYDnxJfNgZKRn6HpVr3rji3ujVu1jjvhFtBDLuJHUt0/lT7pACROcLNGV/HsaWZFMwLAEqMAmq+puWNsT60c7SudMEpKxnaUgjSKRQA6FlOO+eOK1lsnnhaMZYAc+gpunWyCKdOuHbBx0rQMhhjGzj5cn3pSdzVLm+E54xyFE8xeimKQfToarC3Rgnk5Dpwwx+BrVVvPeZG4XAbHvVQtmXcAASAD75rNKyKbs7FG5tyiKURS4PIPQ0y1ddywsQMjAIPrWsUDP7Bd3PNUL62WN4pUONzEEY/z60R2uVK0lZilGmtuWIkhwv4VsTp5otif41IP5cVmwcSgdfOhJbPqM81oWkx/s6Z9o3ROCM/WunmurnDNu1jMvNsiCTB81Rj6Cs7U7AXEOyNQRIMgj171v3SKvm5AIPP51nPD5kAAYqEJI/nWibHy+6n0PPp4IbO+WzMjEKu5Q3GPWtWwiVv7yqeuT29qPHemQ+bbSKWV85DDqKz9B1OS4gy6DeMqTnrVN31FC0Xymw6BN5WRxER09akgmighDzKwY9uxFJHIDGg28elJeP/ou4jOQePSgnkXNdEFxcO5KBsKzZxntXI3w/s7VomixtY/MPWunh2tGSwz5eCM965nxQoAEw4YENj8aqLFNWXodm8StYrKeVdchc9DWBd3LxLKTgbBxntTdMeSeASPI2EXhc8VjancyO/zHh2AIqrak1J+7dMv6Q6NIrTH55GLN9K63TQvktMEAUnbGvv61y/h63S4lJfoO1ddBzHJkcRjKispO7udVBWgS5SD93wd5+Zu9XIVQQPEMuM5z0rLt/mmMjcsVzTtOlkF02XyGPSsbnZyPVJnQ28UKk7U4Hzc1cOVKyEKAR0HWs3e3mByesecVKsjT2u4nDBs5qJu2iFG8tTXh2zsQuPYg8UtwDGcMxyf1qKzITBx2omkLPg9B0rNspR1E+ZicHgnj1/Grdo4CNu6jue9U4ZSOw61bwdoO78hUc1xyHbiV5HB54p/nKIBGI1+X5smmHIVgDyTjNRAfNzycnk1SlbYh6iNcRyMADiXPftU6PvLNHgKevGKomNXm6YKjOavuqpbjA5xkGrvoR5EeUe8bdhFCYziq6uVklOVCL6iooJHKhi2fmI6U9hg7TyGPOaSkbSp20K9y/mWjvgq2cD8Kns3byoBIoywI6c8etVJWZJDg/KXxtPStQP5kSsAFKniri7MUo6WLaxMwV8ttPUVfskYqDnBBOM+lQWc7Miq2CAcVccZdcHAq42epzSbWjK2oI6bdoDZznHNFP1RDHBvjcqc7R9KK25ETF3V0f//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from&nbsp;Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar involvement in Crohn's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 330px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39912=[""].join("\n");
var outline_f38_62_39912=null;
var title_f38_62_39913="Acute otitis media in adults (suppurative and serous)";
var content_f38_62_39913=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute otitis media in adults (suppurative and serous)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/62/39913/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/62/39913/contributors\">",
"     Charles J Limb, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/62/39913/contributors\">",
"     Lawrence R Lustig, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/62/39913/contributors\">",
"     Jerome O Klein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/62/39913/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/62/39913/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/62/39913/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/62/39913/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/62/39913/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otitis media (infection or inflammation of the middle ear) is one of the most common infections, and acute otitis media (AOM) is among the most common diseases that lead to treatment with antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/1\">",
"     1",
"    </a>",
"    ]. AOM primarily occurs in childhood and the medical literature overwhelmingly focuses on the presentation, course, and treatment of AOM in children. The treatment of AOM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/2\">",
"     2",
"    </a>",
"    ] in adults is therefore largely extrapolated from studies in children.",
"   </p>",
"   <p>",
"    Life-threatening complications, though infrequent, may develop because of the proximity of the middle ear and adjacent mastoid to the middle and posterior cranial fossa and related structures. Based upon its high prevalence and potential to cause serious harm, otitis media is a public health concern.",
"   </p>",
"   <p>",
"    This topic will address the etiology, diagnosis, and treatment of AOM in adults. Issues related to AOM in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/35/8760?source=see_link\">",
"     \"Acute otitis media in children: Diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29642?source=see_link\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/0/21514?source=see_link\">",
"     \"Acute otitis media in children: Treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/40/22153?source=see_link\">",
"     \"Otitis media with effusion (serous otitis media) in children\"",
"    </a>",
"    .) Issues related to chronic otitis media in adults are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1450?source=see_link\">",
"     \"Chronic otitis media, cholesteatoma, and mastoiditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION OF OTITIS MEDIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of terms, related to the area of involvement and underlying disease process, are used to categorize infectious or inflammatory conditions of the middle ear. The anatomy of the normal ear is shown in a figure (",
"    <a class=\"graphic graphic_figure graphicRef63141 \" href=\"mobipreview.htm?32/32/33285\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Acute otitis media (AOM)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute otitis media (AOM) is an acute illness marked by the presence of middle ear fluid and inflammation of the mucosa that lines the middle ear space (",
"    <a class=\"graphic graphic_picture graphicRef63268 \" href=\"mobipreview.htm?1/54/1891\">",
"     picture 1",
"    </a>",
"    ). The infection is often caused by obstruction of the eustachian tube, which results in fluid retention and suppuration of retained secretions. AOM may also be associated with purulent otorrhea if there is a ruptured tympanic membrane. AOM usually responds promptly to antimicrobial therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Otitis media with effusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otitis media with effusion (OME) is defined by the presence of middle ear fluid without acute signs of illness or inflammation of the middle ear mucosa. OME usually follows AOM but can result from barotraumas or allergy. OME typically leads to a conductive hearing loss and can be a precursor to retraction and perforation of the tympanic membrane. Eustachian tube dysfunction is often a predisposing factor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute mastoiditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mastoid is that portion of the petrous temporal bone that lies superior to the middle ear cavity (",
"    <a class=\"graphic graphic_figure graphicRef63141 \" href=\"mobipreview.htm?32/32/33285\">",
"     figure 1",
"    </a>",
"    ). The mastoid antrum serves as an air space connecting the middle ear to the mastoid air cells. Thus, most cases of AOM are associated with some degree of mastoid inflammation or infection (\"mastoiditis\"). However, the incidence of clinically significant mastoiditis is low since the introduction of antibacterial drugs.",
"   </p>",
"   <p>",
"    When pus does enter the mastoid air cells under pressure, it may lead to the dissolution of surrounding bone. This represents a serious process that often requires urgent surgical evacuation because the infection can spread to regional structures, including the central nervous system or neck. Mastoiditis can occur at any age but is far more common in children than adults; when it occurs in older adults, it may be particularly severe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14530790\">",
"     'Mastoiditis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Chronic otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic otitis media (COM) is diagnosed in an ear with a tympanic membrane perforation in the setting of chronic ear infections, such as an ear with chronic purulent drainage despite appropriate antibiotic treatment. COM may be benign and is often characterized by a dry tympanic membrane perforation. Continuous serous drainage (typically straw-colored) is termed chronic serous otitis media, and chronic purulent drainage through a perforated tympanic membrane is termed chronic suppurative otitis media. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1450?source=see_link\">",
"     \"Chronic otitis media, cholesteatoma, and mastoiditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY OF AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic studies of acute otitis media (AOM) overwhelmingly involve pediatric or mixed populations. Data are unavailable to determine the incidence of AOM in an adult population. Surveys demonstrate that 80 percent of children will experience one or more episodes of AOM by the age of six [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/4\">",
"     4",
"    </a>",
"    ]. The incidence of AOM markedly decreases after the age of seven.",
"   </p>",
"   <p>",
"    Prior to the introduction of antibiotics, acute coalescent mastoiditis complicated AOM in approximately 20 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/5\">",
"     5",
"    </a>",
"    ]. Current reports indicate that mastoiditis and other infectious complications in adults develop in less than 0.5 percent of cases of AOM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ETIOLOGY OF AOM",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3244861\">",
"    <span class=\"h2\">",
"     Eustachian tube dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important factor in the pathogenesis of middle ear infections is dysfunction of the eustachian tube (",
"    <a class=\"graphic graphic_figure graphicRef63141 \" href=\"mobipreview.htm?32/32/33285\">",
"     figure 1",
"    </a>",
"    ). Descent of the soft palate muscle sling relative to the eustachian tube orifice with adolescence improves the patency of the eustachian tube, resulting in the declining incidence of AOM with age. However, poor tubal function can persist into adulthood.",
"   </p>",
"   <p>",
"    Persistent eustachian tube dysfunction induces a relative negative pressure in the middle ear space. The lack of aeration and the accumulation of effusions provide an environment conducive to the development of AOM or otitis media with effusion (OME).",
"   </p>",
"   <p>",
"    Any entity resulting in eustachian tube dysfunction or obstruction can predispose to AOM. Common causes include seasonal allergic rhinitis and upper respiratory tract infections. Other causes of eustachian tube dysfunction relate to mucosal disease (inflammatory, immunologic impairment, or immotile cilia), extrinsic compression (nasopharyngeal tumor or enlarged adenoid), or palatal muscle dysfunction (cleft palate and other craniofacial anomalies). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/16/8458?source=see_link\">",
"     \"Eustachian tube dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Microbiology",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Bacteriology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The microbiology of AOM has been documented by cultures of middle ear fluids obtained by needle aspiration. Data from adults identify patterns similar to infections in children, with dominance by Streptococcus pneumoniae and Haemophilus influenzae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/1,8,9\">",
"     1,8,9",
"    </a>",
"    ]. Group A beta-hemolytic streptococcus, Staphylococcus aureus, and Moraxella catarrhalis are less frequent causes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      S. pneumoniae is the most important bacterial cause of AOM in adults. Relatively few serotypes are responsible for most disease, although there may be regional differences. The most frequent serotypes responsible for AOM, in decreasing order, are serotypes 19F, 14, 6B, 23F, 6A, and 3 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/10,11\">",
"       10,11",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The seven serotype pneumococcal conjugate vaccine (PCV7) used in children includes types 4, 6B, 9V, 14, 18C, 19F, and 23F. It was developed based upon the most prevalent serotypes responsible for invasive disease, but also includes the major serotypes responsible for AOM, except for 6A and 3. A 13-valent conjugate vaccine (Prevnar 13) was approved by the US Food and Drug Administration in March 2010, with additional serotypes 1, 3, 5, 6A, 7F and 19A. Since the conjugate pneumococcal vaccine protects against carriage of vaccine serotypes, it is likely that the prevalent types responsible for AOM will change in immunized children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/12\">",
"       12",
"      </a>",
"      ]. As an example, H. influenzae may replace pneumococcus as the most frequently isolated pathogen of AOM in children immunized with PCV7 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/13-15\">",
"       13-15",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The durability of protection provided by the infant immunization schedule is uncertain, but appears to be sufficient to cover the preschool years of highest attack rates for both invasive pneumococcal disease and AOM. The",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/8/12422?source=see_link\">",
"       pneumococcal polysaccharide vaccine",
"      </a>",
"      available for older children and adults does not alter carriage of pneumococci, in contrast to the efficacy of PCV7 in decreasing carriage of vaccine serotypes.",
"     </li>",
"     <li>",
"      AOM due to H. influenzae is associated with non-typeable strains in the vast majority of patients of all ages [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/8\">",
"       8",
"      </a>",
"      ]. H. influenzae is the primary pathogen in the unique conjunctivitis-AOM syndrome in children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/16\">",
"       16",
"      </a>",
"      ]. The syndrome has not been identified in adults, but it is possible that strains of H influenzae responsible for AOM in adults include those that cause this syndrome.",
"     </li>",
"     <li>",
"      Staphylococcus aureus, including methicillin-resistant strains, are an uncommon cause of AOM but can occur in patients with chronic suppurative otitis media and may be associated with persistent otorrhea that follows insertion of tympanostomy tubes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Group A streptococcus (GAS) was the leading cause of AOM during the preantibiotic era. The middle ear disease was severe with frequent perforation of the tympanic membrane and mastoiditis. GAS is an uncommon cause of AOM today, though the reason for this is not known [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Other organisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic data suggest that viral infection of the upper respiratory tract is frequently an initial event in the development of AOM. Respiratory viruses have been isolated from the nasopharynx in up to 50 percent of children with AOM and in approximately one quarter of middle ear fluids from children with AOM. The most frequently isolated viruses are respiratory syncytial virus, influenza viruses, and rhinoviruses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Combined bacterial and viral infections appear to be more severe than viral or bacterial episodes of AOM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Experimental infection of adult volunteers with Mycoplasma pneumoniae resulted in hemorrhagic bullous myringitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/22\">",
"     22",
"    </a>",
"    ]. However, in the many studies of the microbiology of AOM, M. pneumoniae has rarely been identified. Some patients with lower respiratory tract infection due to M. pneumoniae have concurrent AOM, although the etiologic role of M. pneumoniae in the AOM is uncertain.",
"   </p>",
"   <p>",
"    Fungi are frequently associated with otitis externa. Candida and Aspergillus species, although infrequent, have been isolated from middle ear fluids of patients who developed chronic suppurative otitis media [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other uncommon causes of AOM include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chlamydia trachomatis",
"     </li>",
"     <li>",
"      Diphtheritic otitis",
"     </li>",
"     <li>",
"      Tuberculous otitis",
"     </li>",
"     <li>",
"      Otogenous tetanus",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Biofilms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of biofilms in the pathophysiology of infections of the upper aerodigestive tract is increasingly recognized, particularly in antibiotic-resistant cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/2,24,25\">",
"     2,24,25",
"    </a>",
"    ]. A biofilm begins as an aggregate of bacteria that attach to a surface. Such bacteria demonstrate reduced metabolism and replication rates.",
"   </p>",
"   <p>",
"    Biofilms are difficult to eradicate since antibiotics cannot readily penetrate the formed matrix. The problem is confounded by the difficulty in culturing biofilms. Biofilms have been identified in cholesteatomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/26\">",
"     26",
"    </a>",
"    ] and tympanostomy tubes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/27\">",
"     27",
"    </a>",
"    ], supporting their role in resistant infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Immunology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The respiratory mucosal membrane that lines the middle ear space and mastoid air cells provides an immunologic defensive barrier. The constantly renewed mucus that forms this barrier is rich in lysozyme, a potent antibacterial enzyme [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/28\">",
"     28",
"    </a>",
"    ]. Mucus production increases in response to an invading organism. In addition, inflammatory dilation of vessels, white blood cell migration, proteolytic enzyme activity, and antibody deposition contribute to the formation of mucopurulent secretions.",
"   </p>",
"   <p>",
"    All of the major classes of immunoglobulins have been identified in middle ear effusions of patients with AOM. The presence of these type-specific antibodies in middle ear effusions is associated with clearance of mucopurulent secretions and an early return to normal middle ear function.",
"   </p>",
"   <p>",
"    The incidence of AOM and related complications is increased in children with congenital or acquired immunologic deficiencies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/28\">",
"     28",
"    </a>",
"    ], a risk that persists into adulthood. The risks of AOM and its complications are also increased in patients who have a concomitant malignancy, use immunosuppressive drugs, or have a history of previous irradiation to the nasopharyngeal region [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS OF AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of AOM in adults is typically associated with otalgia (ear pain) and decreased hearing. Fever may not be present. A preceding upper respiratory tract infection or exacerbation of seasonal allergic rhinitis may herald the onset of AOM by several days.",
"   </p>",
"   <p>",
"    There is considerable variability in the symptoms and signs of AOM. The infection is typically but not always unilateral. A bulging tympanic membrane distinguishes acute otitis media from otitis media with effusion. (",
"    <a class=\"graphic graphic_picture graphicRef63268 \" href=\"mobipreview.htm?1/54/1891\">",
"     picture 1",
"    </a>",
"    ). The tympanic membrane may also be erythematous or opacified. If the tympanic membrane has ruptured (often reported by the patient as a relief of the otalgia), there may also be associated purulent otorrhea.",
"   </p>",
"   <p>",
"    Dysequilibrium is described infrequently. Conductive hearing loss is usually transient. Other symptoms, such as high fever, severe pain behind the ear, or facial paralysis, suggest unusual complications (See",
"    <a class=\"local\" href=\"#H29565560\">",
"     'Complications of AOM'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to make an accurate diagnosis of AOM to avoid the inappropriate use of antibiotics and the associated increase in antibiotic-resistance rates.",
"   </p>",
"   <p>",
"    Examination with a hand-held otoscope is the standard method of diagnosis of AOM. The addition of pneumatoscopy allows evaluation of tympanic membrane motion and is thus highly recommended for diagnosis. Otomicroscopy, available in otorhinology specialty practices, allows even greater definition of the tympanic membrane.",
"   </p>",
"   <p>",
"    Examination typically demonstrates tympanic membrane redness, opacification, bulging (",
"    <a class=\"graphic graphic_picture graphicRef63268 \" href=\"mobipreview.htm?1/54/1891\">",
"     picture 1",
"    </a>",
"    ), and poor mobility when pneumatic pressure is applied using a pneumatic otoscope (",
"    <a class=\"graphic graphic_movie graphicRef70700 \" href=\"mobipreview.htm?24/11/24766\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63633 \" href=\"mobipreview.htm?38/53/39774\">",
"     picture 2",
"    </a>",
"    ). The tympanic membrane is normally translucent (",
"    <a class=\"graphic graphic_picture graphicRef52626 \" href=\"mobipreview.htm?5/14/5345\">",
"     picture 3",
"    </a>",
"    ). In contrast, the tympanic membrane appears cloudy or opaque when there is fluid in the middle ear. An air-fluid level is present when the tympanic membrane appears translucent above and opaque below the line of demarcation (",
"    <a class=\"graphic graphic_picture graphicRef67379 \" href=\"mobipreview.htm?20/6/20576\">",
"     picture 4",
"    </a>",
"    ). In addition, there may be purulence in the ear canal if there is an associated tympanic membrane rupture.",
"   </p>",
"   <p>",
"    The predictive value and accuracy of abnormal otoscope findings have not been reported for AOM in adults but has been studied in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. In one study, flawed by the lack of bacterial cultures and selective performance of myringotomy to confirm the diagnosis, the predictive value of combinations of clinical findings was estimated (",
"    <a class=\"graphic graphic_table graphicRef75969 \" href=\"mobipreview.htm?7/32/7693\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/32\">",
"     32",
"    </a>",
"    ]. The triad of bulging tympanic membrane, impaired mobility, and redness or cloudiness of the tympanic membrane predicted the diagnosis of AOM, confirmed at myringotomy, in 83 to 99 percent of cases. Another study found that a bulging tympanic membrane was more likely to predict AOM than a distinctly red tympanic membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A tuning fork examination (512 Hz) may demonstrate conductive hearing loss. The Weber test is performed by placing the fork on the vertex of the forehead; the perceived sound will be louder in the infected ear (",
"    <a class=\"graphic graphic_figure graphicRef58032 \" href=\"mobipreview.htm?40/5/41043\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40015059\">",
"    <span class=\"h2\">",
"     Bullous myringitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bullous myringitis is a presentation of AOM in which blisters (bullae) are seen on the tympanic membrane. Despite earlier belief that this condition was associated with mycoplasmal infection, more recent evidence indicates that the prevalence of viral, bacterial, or mycoplasmal infection is the same in bullous myringitis as in nonbullous otitis media [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/33\">",
"     33",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_picture graphicRef86980 \" href=\"mobipreview.htm?12/26/12706\">",
"     picture 5",
"    </a>",
"    ). Bullous myringitis can be particularly painful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40015052\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS OF AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of acute otitis media includes otitis externa, eustachian tube dysfunction, nasopharyngeal pathology including herpes zoster infection, and other head and neck infections.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AOM can usually be differentiated from otitis externa in that the latter tends to be more painful, especially with mild traction on the outer ear, and there is a normal-appearing ear drum on examination.",
"     </li>",
"     <li>",
"      Patients with recurrent unilateral AOM (ie, more than two episodes over a six month time period) should undergo investigation for eustachian tube or nasopharyngeal pathology. Fiberoptic nasopharyngoscopy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      contrast MRI of the skull base and nasopharynx should be performed to rule out the possibility of a malignant process obstructing the eustachian tube orifice.",
"     </li>",
"     <li>",
"      The diagnosis of herpes zoster is established with development of a typical dermatomal vesicular rash that evolves into crusted lesions. Prodromal pain may precede the rash by several days and, less commonly, a week or more. The Ramsay Hunt syndrome (herpes zoster oticus) is characterized by the triad of ipsilateral facial paralysis, ear pain, and vesicles involving the auditory canal and auricle, and can also cause vertigo. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/20/2378?source=see_link&amp;anchor=H3#H3\">",
"       \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'Rash'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/20/2378?source=see_link&amp;anchor=H15#H15\">",
"       \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'Ramsay Hunt syndrome (Herpes zoster oticus)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Deep space head and neck infections are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=see_link\">",
"       \"Deep neck space infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT OF AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics are the mainstay of treatment of uncomplicated suppurative acute otitis media in adults. Consistent results from bacteriologic studies of middle ear effusions in children and adults with AOM suggest that the choice of antimicrobial agents may be based on knowledge of the bacteriology of AOM, rather than results of cultures from adjacent sites such as the throat or nasopharynx.",
"   </p>",
"   <p>",
"    Microbiologic results indicate that at least one-quarter of children have AOM due to a viral respiratory pathogen, and that some of the episodes of AOM resolve without antibacterial agents. Among children with AOM, approximately 19 percent of pneumococcal, and up to one-half of H. influenzae AOM cases resolve and fluid samples from the middle ear become sterile without antibacterial drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. These results prompted some European clinicians to withhold antibiotic therapy from children with ear infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/36\">",
"     36",
"    </a>",
"    ]. The option of observation of children with AOM, rather than initial antimicrobial therapy, is practiced extensively in Western Europe.",
"   </p>",
"   <p>",
"    In 2004 the American Academy of Pediatrics and the American Academy of Family Physicians proposed a similar protocol for withholding antimicrobial therapy for children who were older than two years of age, whose diagnosis was uncertain, and who did not have severe disease (eg, moderate to severe otalgia with fever &ge;39&deg;C) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/37\">",
"     37",
"    </a>",
"    ]. There are no data about withholding antimicrobial drugs from adult patients with AOM. At this time, it is prudent to treat adults with antibiotic therapy for a diagnosis of AOM to prevent the potential for complications of an untreated infection. (See",
"    <a class=\"local\" href=\"#H29565560\">",
"     'Complications of AOM'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    While awaiting response to antibiotic therapy, it is important to address the relief of pain, which can be significant. Most patients will symptomatically improve with a mild analgesic, such as a nonsteroidal antiinflammatory medication, although a short course of opioids is occasionally indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Choice of initial antibiotic",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preferred antibacterial drug for the patient with AOM must be active against S. pneumoniae, H. influenzae, and M. catarrhalis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. A 2001 meta-analysis concluded that there is no evidence to support any particular antibiotic regimen versus another for treatment of AOM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"     Amoxicillin",
"    </a>",
"    remains the drug of choice for initial therapy of AOM because of its 25-year record of clinical success, acceptability, limited side effects, and relatively low cost. Amoxicillin is ineffective against beta-lactamase producing H. influenzae and M. catarrhalis, but the current incidence of ampicillin-resistant strains is not sufficiently high to require a change in initial therapy. However,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    should be considered for patients with severe otalgia or elevated temperature to cover the possibility of beta-lactamase producing H. influenzae. The usual dose of amoxicillin is:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mild to moderate disease: 500 mg every 12 hours, or 250 mg every 8 hours",
"     </li>",
"     <li>",
"      Severe disease (eg, patients with fever, significant hearing loss, severe pain,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      marked erythema): 875 mg every 12 hours, or 500 mg every 8 hours",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some experts recommend dosages of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    for adults up to 2 g every eight hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/43\">",
"     43",
"    </a>",
"    ]. Such higher doses may be indicated in communities in which there is a significant prevalence of strains of Streptococcus pneumoniae that are not fully susceptible to penicillin.",
"   </p>",
"   <p>",
"    We suggest that patients with mild to moderate disease be treated for five to seven days, and those with more severe disease receive a 10-day course of antibiotic. There is little evidence regarding optimal duration of therapy for adults with AOM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Penicillin allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acceptable alternatives to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    in patients with allergy to penicillin depend upon the type of the previous hypersensitivity reaction.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients who report penicillin allergy but who did not experience a type 1 hypersensitivity reaction (urticaria or anaphylaxis), we suggest one of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/21/5461?source=see_link\">",
"       Cefdinir",
"      </a>",
"      (300 mg twice a day or 600 mg once daily)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/44/27333?source=see_link\">",
"       Cefpodoxime",
"      </a>",
"      (200 mg twice a day)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/61/26583?source=see_link\">",
"       Cefuroxime",
"      </a>",
"      (500 mg every 12 hours)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      (2 g IM or IV once)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with known and severe allergy to beta-lactam antibiotics, a macrolide (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      combined with sulfisoxazole, or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/57/10138?source=see_link\">",
"       clarithromycin",
"      </a>",
"      ) is the preferred drug.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"       Trimethoprim-sulfamethoxazole",
"      </a>",
"      may be used in regions where pneumococcal resistance to this combination is not a concern.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Lack of initial response",
"    </span>",
"    &nbsp;&mdash;&nbsp;With appropriate antimicrobial therapy, most patients with AOM are significantly improved within 48 to 72 hours. If there is no improvement, the patient should be reexamined. The patient may have developed a new focus of infection or have received inadequate therapy.",
"   </p>",
"   <p>",
"    When",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    fails, the patient should be treated with a subsequent course of an antibiotic with a broader activity spectrum for another 10-day course. Appropriate second-line regimens include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/56/43912?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    (combination of amoxicillin plus the beta-lactamase inhibitor clavulanate), a second-generation cephalosporin such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/61/26583?source=see_link\">",
"     cefuroxime",
"    </a>",
"    axetil, or a third-generation cephalosporin (such as oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/21/5461?source=see_link\">",
"     cefdinir",
"    </a>",
"    or intramuscular",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Ruptured tympanic membrane",
"    </span>",
"    &nbsp;&mdash;&nbsp;When infection results in acute rupture of the tympanic membrane, treatment consists of a combination of oral and topical antibiotics, as well as preventing water entry into the ear canal. Ototopic drugs that have low acidity and low ototoxicity, such as Floxin otic, are preferred;",
"    <span class=\"nowrap\">",
"     acidic/antiseptic",
"    </span>",
"    agents, as well as topical agents containing aminoglycosides or alcohol, should be avoided when the middle ear space is open (",
"    <a class=\"graphic graphic_table graphicRef67418 \" href=\"mobipreview.htm?8/45/8925\">",
"     table 2",
"    </a>",
"    ). Although there are no definitive data showing that commonly used preparations such as",
"    <span class=\"nowrap\">",
"     polymyxin/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?13/57/14229?source=see_link\">",
"      neomycin",
"     </a>",
"    </span>",
"    drops cause hearing loss in these circumstances, there is an explicit manufacturer warning not to use",
"    <span class=\"nowrap\">",
"     neomycin/",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?17/20/17733?source=see_link\">",
"      polymyxin B",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"      hydrocortisone",
"     </a>",
"    </span>",
"    for a nonintact tympanic membrane.",
"   </p>",
"   <p>",
"    In most cases, the ruptured tympanic membrane will heal. The perforation permits drainage of the middle ear abscess and relieves increased middle ear pressure. With the relief of middle ear pressure, the extensively vascularized tympanic membrane usually heals quickly, sealing the perforation within days. Persistent subjective hearing loss following resolution of the infection should be followed-up with an audiogram and otolaryngologic consultation.",
"   </p>",
"   <p>",
"    Chronic perforations may occur. A chronically-infected middle ear or mastoid may result in persistent suppurative drainage (chronic suppurative otitis media, CSOM). Patients with perforation that persists for six weeks or longer (with or without suppurative drainage) should be referred to an otolaryngologist for further management. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1450?source=see_link\">",
"     \"Chronic otitis media, cholesteatoma, and mastoiditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565560\">",
"    <span class=\"h1\">",
"     COMPLICATIONS OF AOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of acute ear disease can occur in the setting of host factors such as immune status and individual anatomy, or incomplete treatment. Complications may result from seeding of vascular channels and extension along preformed pathways (such as the oval window, round window, internal auditory canal, or endolymphatic duct) and are typically divided into intratemporal or extratemporal classifications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565569\">",
"    <span class=\"h2\">",
"     Intratemporal complications",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14530790\">",
"    <span class=\"h3\">",
"     Mastoiditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A spectrum of disease is associated with mastoiditis. Mastoid effusion is often seen on CT scan in patients with AOM and is not usually clinically significant. Symptomatic mastoiditis is a rare complication of both acute and chronic otitis media, but can be serious due to proximity of the mastoid to the posterior cranial fossa, lateral sinuses, facial nerve canal, semicircular canals, and the petrous tip of the temporal bone.",
"   </p>",
"   <p>",
"    Acute mastoiditis occurs more commonly in children than adults, and its incidence has declined dramatically in the antibiotic era with routine use of antibiotics for treatment of otitis media. It is a rare occurrence in adults. In a study of patients with acute mastoiditis admitted to two hospitals in Sweden between 1996 and 2000, only 3 of the 42 patients were older than 18 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/44\">",
"     44",
"    </a>",
"    ]. Two of the three adults had prior cranial surgery on the same side as the mastoiditis. Mastoiditis may be clinically more severe in older adults, however [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical mastoiditis may present with fever, posterior ear pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    local erythema over the mastoid bone, edema of the pinna, or a posteriorly and downward displaced auricle. In coalescent mastoiditis, CT demonstrates characteristic loss of the trabecular bone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT scan should always be performed when mastoiditis is suspected. If there is a concern for an intracranial process (ie, sigmoid sinus thrombosis, intracranial abscess), then an MRI scan should also be considered. Patients with acute mastoiditis should be admitted to the hospital and started on IV antibiotics. When mastoiditis occurs as a complication of acute otitis media, antibiotics with activity against Streptococcus pneumoniae and Haemophilus influenzae should be started. When mastoiditis presents as a complication of more chronic disease, coverage should include Staphylococcus aureus, Pseudomonas, and enteric gram-negative rods.",
"   </p>",
"   <p>",
"    If patients do not respond to conservative therapy with IV antibiotics, further intervention is warranted. This involves mastoidectomy for debridement of necrotic bone. Myringotomy is an adjunct to mastoidectomy for the treatment of acute mastoiditis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1450?source=see_link&amp;anchor=H26969910#H26969910\">",
"     \"Chronic otitis media, cholesteatoma, and mastoiditis in adults\", section on 'Surgical treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565577\">",
"    <span class=\"h3\">",
"     Facial paralysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Facial paralysis is usually attributed to direct neurocompression through a dehiscence in the bone covering the facial nerve, usually in the tympanic or vertical mastoid portions. Through destruction of the overlying bone by cholesteatoma or osteitis, endoneuritis may develop. Surgical decompression of the affected area is recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565584\">",
"    <span class=\"h3\">",
"     Labyrinthitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Labyrinthitis presents as nausea, vomiting, vertigo, tinnitus, and hearing loss in the setting of both acute and chronic ear infections. &nbsp;A picture of labyrinthitis in the setting of acute otitis media may occur as a result of serous labyrinthitis, a pre-suppurative condition in which the labyrinth undergoes inflammatory changes in association with acute suppurative otitis media. Serous labyrinthitis is not associated with permanent auditory or vestibular dysfunction. Treatment is predominantly medical, unless persistent granulation tissue or cholesteatoma are present. In contrast, purulent labyrinthitis presents with intense vertigo, tinnitus, hearing loss, vomiting, nausea, and a picture of acute toxicity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13559?source=see_link\">",
"     \"Treatment of vertigo\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565591\">",
"    <span class=\"h3\">",
"     Hearing loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of intratemporal changes can produce hearing loss in the context of both acute and chronic ear infections, though are more commonly seen in cases of chronic otitis media. The hearing loss is usually conductive in nature due to ossicular erosion or tympanic membrane perforation. Sensorineural hearing loss may occur, particularly in the setting of a new infection in an adult without a prior history of ear infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565598\">",
"    <span class=\"h3\">",
"     Petrositis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The petrous apex of the temporal bone is anatomically closely related to critical neural and vascular structures. As a result, infections of the petrous apex can result in severe neural compromise. Because of the extensive pneumatization and presence of rich bone marrow within the petrous apex, it is susceptible to infection or inflammation, typically in combination with mastoiditis. The inflammation may extend into Dorello&rsquo;s canal transmitting the VIth cranial nerve and the Gasserian ganglion, causing the triad of symptoms known as &ldquo;Gradenigo Syndrome&rdquo;: lateral rectus palsy, retro-orbital pain, and otorrhea. The presence of both otorrhea and deep pain should lead one to suspect petrous apicitis.",
"   </p>",
"   <p>",
"    The most common organism responsible for petrous apicitis is Pseudomonas aeruginosa. The acute form typically develops over a rapid period of time and is due to sudden obstruction of a normally-pneumatized petrous apex air cell system. Diagnosis is affirmed by temporal bone CT, demonstrating opacification of the mastoid air cells system and petrous apex, enhancement of the cavernous sinus, and bony erosion within the petrous apex. High-resolution MRI with gadolinium through the temporal bone will demonstrate a low-intensity signal on T1-weighted images, high-intensity signal on T2-weighted images, and ring enhancement. MRI findings are important in distinguishing petrous apicitis from other lesions of the petrous apex. Treatment consists of antibiotic therapy, with surgical exploration reserved for those who do not respond to appropriate antibiotics or develop complications from the infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Even with surgical drainage, prolonged postoperative antibiotics are usually recommended, typically for a period of up to six weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565607\">",
"    <span class=\"h2\">",
"     Extratemporal complications",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565636\">",
"    <span class=\"h3\">",
"     Epidural, subdural, and brain abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidural abscesses present most commonly as headache that is occasionally relieved by profuse drainage from the ear. Treatment requires surgical drainage after identification of the abscess on MRI or CT imaging. Epidural abscesses occur most commonly secondary to erosion of the posterior fossa plate. Less commonly, erosion of the tegmen mastoideum can lead to an epidural abscess. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17033?source=see_link\">",
"     \"Epidural abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presentation of a subdural abscess may closely mirror that of an epidural abscess. Neurologic signs are more likely to accompany abscesses that occur in the subdural space, between the dura and arachnoid meningeal layers. The mechanism underlying the development of a subdural abscess is thought to be bone erosion followed by thrombophlebitis.",
"   </p>",
"   <p>",
"    Brain abscesses in association with chronic ear infections will typically involve the temporal lobe or cerebellum. Treatment requires drainage of the brain abscess by a neurosurgeon, followed by surgical eradication of the mastoid infection. Successful management of brain abscesses typically requires a prolonged course of potent antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38104?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of brain abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32438?source=see_link\">",
"     \"Treatment and prognosis of brain abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565646\">",
"    <span class=\"h3\">",
"     Otitic hydrocephalus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otitis hydrocephalus refers to a syndrome of increased intracranial pressure and suppurative otitis media in the absence of a brain abscess or meningitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/48\">",
"     48",
"    </a>",
"    ]. The typical case of otitic hydrocephalus occurs following prolonged otitis media. The most common symptom is headache on the side of the involved ear. Papilledema is noted and evidence of hydrocephalus is seen on cranial imaging by CT or MRI. The pathogenesis behind otitic hydrocephalus appears to involve abnormal cerebrospinal fluid metabolism from inflamed meninges. Appropriate management of the ear disease and conventional measures of lowering intracranial pressure are indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565654\">",
"    <span class=\"h3\">",
"     Otitic meningitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otitic meningitis in association with both acute and chronic ear disease may progress to general patterns of involvement of the meninges. The offending pathogen is usually H. influenzae, although S. pneumoniae and, to a lesser extent, Neisseria meningitidis can also be implicated. The meningitis may be local, in which case cerebrospinal fluid analysis may be negative for bacteria. Usually, however, the meningitis is generalized, and lumbar puncture with spinal fluid studies demonstrate bacteria. Otitic meningitis is the most common intracranial complication from chronic otitis and mastoiditis, although meningitis may occur in association with acute otitis media as well. All forms of otitic meningitis typically present with the classic signs of meningitis, including fever, neck pain, photophobia, and mental status changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/49\">",
"     49",
"    </a>",
"    ]. Treatment requires antibiosis and surgical removal of cholesteatoma",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    granulation tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29565663\">",
"    <span class=\"h3\">",
"     Lateral sinus thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lateral, or sigmoid sinus, runs through the posterior portion of the mastoid cortex, where it has a characteristic curvature and eventually forms the jugular bulb and internal jugular vein. Septic lateral sinus thrombosis is exclusively associated with infection of the mastoid air cells. Lateral sinus thrombosis is often subacute in onset, with a persistent earache as the first symptom persisting for several weeks before the onset of headache. Anemia, increased signs of increased intracranial pressure, lower cranial neuropathies, and Greisinger&rsquo;s sign (postauricular edema from emissary vein thrombophlebitis) may result in advanced stages of the disease. Sigmoid thrombophlebitis may extend to the jugular vein, with resultant internal jugular vein thrombosis. Treatment requires drainage of the perisinus abscess via a transmastoid approach, exposure of the sigmoid sinus, and antibiotics. If there are signs of systemic embolization (eg, pulmonary embolus), anticoagulation may be indicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23145?source=see_link&amp;anchor=H18#H18\">",
"     \"Septic dural sinus thrombosis\", section on 'Septic lateral sinus thrombosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     OTITIS MEDIA WITH EFFUSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;OME is often characterized by hearing loss or aural fullness, and possibly a history of recurrent episodes of AOM. There may be an antecedent upper respiratory tract infection, exacerbation in seasonal allergy symptoms, or airplane travel.",
"   </p>",
"   <p>",
"    Otoscopic findings of OME are fluid (often yellowish, but sometimes clear), and visible behind a retracted tympanic membrane. A normal tympanic membrane is shown in a photograph (",
"    <a class=\"graphic graphic_picture graphicRef52626 \" href=\"mobipreview.htm?5/14/5345\">",
"     picture 3",
"    </a>",
"    ), to be compared with a retracted tympanic membrane (",
"    <a class=\"graphic graphic_picture graphicRef52819 \" href=\"mobipreview.htm?18/49/19217\">",
"     picture 6",
"    </a>",
"    ). Viscous bubbles may also be seen, particularly during pneumatic otoscopy. Pneumatic otoscopy demonstrates reduced mobility of the ear drum.",
"   </p>",
"   <p>",
"    Tympanometry, the best means of diagnosis, will demonstrate a flat (type C) configuration. Patients with symptoms of ear fullness associated with hearing loss",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    visualization of an opaque or yellowish tympanic membrane on pneumatic otoscopy should be referred for tympanometry with audiometry. Audiometry will reveal the presence of a mild to moderate conductive hearing loss. If sensorineural hearing loss is demonstrated, particularly in the presence of normal tympanometry, immediate referral to an otolaryngologist is warranted for possible therapy with glucocorticoids and to rule out a retrocochlear lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Treatment for OME",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, OME resolves spontaneously without treatment. In a small percentage of cases, the effusion persists and requires additional intervention, such as pressure equalization tubes.",
"   </p>",
"   <p>",
"    Simple maneuvers such as autoinsufflation (pinching the nose while gently exhaling, forcing air back through the eustachian tube and repressurizing the ear) may be helpful, although a systematic review of small studies of autoinsufflation in children did not demonstrate a significant difference in tympanometry results between intervention and control patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/50\">",
"     50",
"    </a>",
"    ]. Studies are not available in adults, but the maneuver is of no cost, without adverse effects, and may be helpful to some.",
"   </p>",
"   <p>",
"    Otitis media with effusion develops primarily from a",
"    <span class=\"nowrap\">",
"     mechanical/obstructive",
"    </span>",
"    phenomenon. There is no evidence that decongestants and antihistamines are beneficial in the treatment of OME in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/51\">",
"     51",
"    </a>",
"    ]. However, in adults, seasonal allergic rhinitis or nasopharyngeal swelling from an upper respiratory tract infection can induce eustachian tube dysfunction. As a result, most patients are treated with decongestants, antihistamines, or nasal steroids despite a lack of data demonstrating a clear benefit in OME. Decongestants might cause some symptom relief by alleviating nasal congestion. A majority of effusions will resolve over the course of 12 weeks, and most patients can be observed over this time period.",
"   </p>",
"   <p>",
"    If the effusion does not resolve over this time period, or if there are pressing needs to provide pressure equalization or improved hearing (eg, anticipated airplane travel that cannot be deferred until OME resolves), then myringotomy with tube placement should be performed. Case series have shown myringotomy for OME to be effective with few adverse effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/52\">",
"     52",
"    </a>",
"    ]; there are no available randomized trials of myringotomy for the treatment of OME in adults.",
"   </p>",
"   <p>",
"    Myringotomy is contraindicated in patients with irreversible eustachian tube dysfunction secondary to etiologies such as cancer or radiation therapy involving the eustachian tube. Placement of a tube in such patients can potentially result in chronic otorrhea. Hearing loss from an effusion in these patients must be weighed against the potential development of a chronically draining ear with tympanostomy tube placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/62/39913/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute otitis media (AOM) is an acute illness with middle ear fluid and inflammation of the mucosal lining of the middle ear space. Purulent otorrhea may be present through a ruptured tympanic membrane. Otitis media with effusion (OME) is the presence of middle ear fluid without inflammation, and usually results from barotraumas or allergy. Acute mastoiditis, inflammation of the petrous bone adjacent to the middle ear, is infrequently clinically significant, but may be severe in older adults. Chronic suppurative otitis media (CSOM) occurs with a perforated tympanic membrane in the setting of chronic ear infections. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification of otitis media'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Eustachian tube dysfunction, commonly related to seasonal allergic rhinitis or upper respiratory tract infection, is the most important factor in the pathogenesis of middle ear infections. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Etiology of AOM'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common bacteria causing AOM in both children and adults are Streptococcus pneumoniae and Haemophilus influenzae. Group A beta-hemolytic streptococcus, Staphylococcus aureus, and Moraxella catarrhalis are less frequent causes. Childhood immunization with conjugate pneumococcal vaccine may affect current microbial prevalence data. Respiratory viruses have been isolated from a quarter of middle ear fluids sampled from children with AOM. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The onset of AOM is associated with otalgia and decreased hearing. AOM is typically unilateral and drainage may be present if the tympanic membrane has ruptured. The tympanic membrane is red, opacified, bulging and immotile, and a conductive hearing loss may be demonstrated. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Clinical manifestations of AOM'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis of AOM'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that adults with AOM be managed with antibiotic treatment rather than \"watchful waiting\" (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). The preferred antibacterial drug for the patient with AOM must be active against S. pneumoniae, H. influenzae, and M. catarrhalis. There is no evidence to support any particular antibiotic regimen versus another for treatment of AOM. Based on its acceptability and low cost, we typically use",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      500 mg three times a day for five to seven days as initial therapy for AOM in patients without penicillin allergy. A macrolide (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      combined with sulfisoxazole, or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"       azithromycin",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/57/10138?source=see_link\">",
"       clarithromycin",
"      </a>",
"      ) is the preferred drug for penicillin allergic patients. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Treatment of AOM'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who do not respond symptomatically within 48 to 72 hours should be reexamined. Treatment regimens for patients who did not respond to the initial antibiotic course include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/56/43912?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      or a second-generation cephalosporin. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Lack of initial response'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Otitis media with effusion (OME) is characterized by hearing loss or aural fullness and possibly a history of recurrent episodes of AOM. Otoscopy reveals fluid and an immobile retracted membrane; tympanometry is the best means of diagnosis. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Otitis media with effusion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A majority of effusions will resolve over the course of 12 weeks, and most patients with OME can be observed over this time period. We suggest a trial of oral decongestants during this time (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Patients should be instructed in autoinsufflation as a low-cost intervention. Myringotomy with tympanostomy tubes may be considered for persistent symptomatic effusions at 12 weeks, and earlier for selected patients with need for immediate pressure equalization (eg, air travel that cannot be deferred). (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Treatment for OME'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Gates GA. Acute otitis media and otitis media with effusion. In: Otolaryngology: Head &amp; Neck Surgery, Cummings C, Frederickson J, Harker L (Eds), Mosby, Baltimore 1998. p.461.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/2\">",
"      Bakaletz LO. Bacterial biofilms in otitis media: evidence and relevance. Pediatr Infect Dis J 2007; 26:S17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/3\">",
"      Samuels MA, Gonzalez RG, Kim AY, Stemmer-Rachamimov A. Case records of the Massachusetts General Hospital. Case 34-2007. A 77-year-old man with ear pain, difficulty speaking, and altered mental status. N Engl J Med 2007; 357:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/4\">",
"      Brownlee RC Jr, DeLoache WR, Cowan CC Jr, Jackson HP. Otitis media in children. Incidence, treatment, and prognosis in pediatric practice. J Pediatr 1969; 75:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/5\">",
"      HOUSE HP. Otitis media; a comparative study of the results obtained in therapy before and after the introduction of the sulfonamide compounds. Arch Otolaryngol 1946; 43:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/6\">",
"      Hafidh MA, Keogh I, Walsh RM, et al. Otogenic intracranial complications. a 7-year retrospective review. Am J Otolaryngol 2006; 27:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/7\">",
"      Leskinen K, Jero J. Acute complications of otitis media in adults. Clin Otolaryngol 2005; 30:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/8\">",
"      Celin SE, Bluestone CD, Stephenson J, et al. Bacteriology of acute otitis media in adults. JAMA 1991; 266:2249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/9\">",
"      Schwartz LE, Brown RB. Purulent otitis media in adults. Arch Intern Med 1992; 152:2301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/10\">",
"      Austrian R, Howie VM, Ploussard JH. The bacteriology of pneumococcal otitis media. Johns Hopkins Med J 1977; 141:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/11\">",
"      Gray BM, Converse GM 3rd, Dillon HC Jr. Serotypes of Streptococcus pneumoniae causing disease. J Infect Dis 1979; 140:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/12\">",
"      Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/13\">",
"      Benninger MS. Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine. Otolaryngol Head Neck Surg 2008; 138:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/14\">",
"      Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/15\">",
"      Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/16\">",
"      Bodor FF, Marchant CD, Shurin PA, Barenkamp SJ. Bacterial etiology of conjunctivitis-otitis media syndrome. Pediatrics 1985; 76:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/17\">",
"      Hartnick CJ, Shott S, Willging JP, Myer CM 3rd. Methicillin-resistant Staphylococcus aureus otorrhea after tympanostomy tube placement: an emerging concern. Arch Otolaryngol Head Neck Surg 2000; 126:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/18\">",
"      Segal N, Givon-Lavi N, Leibovitz E, et al. Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis 2005; 41:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/19\">",
"      Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis 2006; 43:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/20\">",
"      Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis 2008; 46:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/21\">",
"      Chonmaitree T, Owen MJ, Howie VM. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis 1990; 162:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/22\">",
"      RIFKIND D, CHANOCK R, KRAVETZ H, et al. Ear involvement (myringitis) and primary atypical pneumonia following inoculation of volunteers with Eaton agent. Am Rev Respir Dis 1962; 85:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/23\">",
"      Ibekwe AO, al Shareef Z, Benayam A. Anaerobes and fungi in chronic suppurative otitis media. Ann Otol Rhinol Laryngol 1997; 106:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/24\">",
"      Macassey E, Dawes P. Biofilms and their role in otorhinolaryngological disease. J Laryngol Otol 2008; 122:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/25\">",
"      Post JC, Hiller NL, Nistico L, et al. The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg 2007; 15:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/26\">",
"      Chole RA, Faddis BT. Evidence for microbial biofilms in cholesteatomas. Arch Otolaryngol Head Neck Surg 2002; 128:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/27\">",
"      Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001; 111:2083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/28\">",
"      Ilia S, Goulielmos GN, Samonis G, Galanakis E. Host's response in otitis media: understanding genetic susceptibility. Pediatr Infect Dis J 2008; 27:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/29\">",
"      Wang SZ, Wang WF, Zhang HY, et al. Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion. Radiother Oncol 2007; 85:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/30\">",
"      Rothman R, Owens T, Simel DL. Does this child have acute otitis media? JAMA 2003; 290:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/31\">",
"      Karma PH, Penttil&auml; MA, Sipil&auml; MM, Kataja MJ. Otoscopic diagnosis of middle ear effusion in acute and non-acute otitis media. I. The value of different otoscopic findings. Int J Pediatr Otorhinolaryngol 1989; 17:37.",
"     </a>",
"    </li>",
"    <li>",
"     Karma PH, Sipila MM, Kayaja MJ, Penttila MA. Pneumatic otoscopy and otitis media: The value of different tympanic membrane findings and their combinations. In: Recent advances in otitis media: proceedings of the Fifth International Symposium, Lim DJ, Bluestone CD, Klein JO, et al (Eds), Decker, Burlington, Ontario 1993. p.41.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/33\">",
"      Roberts DB. The etiology of bullous myringitis and the role of mycoplasmas in ear disease: a review. Pediatrics 1980; 65:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/34\">",
"      Howie VM, Ploussard JH. The \"in vivo sensitivity test\"--bacteriology of middle ear exudate, during antimicrobial therapy in otitis media. Pediatrics 1969; 44:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/35\">",
"      Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 1991; 87:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/36\">",
"      van Buchem FL, Dunk JH, van't Hof MA. Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children. Lancet 1981; 2:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/37\">",
"      American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/38\">",
"      Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998; 42:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/39\">",
"      Kaplan SL. The emergence of resistant pneumococcus as a pathogen in childhood upper respiratory tract infections. Semin Respir Infect 1995; 10:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/40\">",
"      Pichichero ME, Casey JR. Acute otitis media disease management. Minerva Pediatr 2003; 55:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/41\">",
"      Thanaviratananich S, Laopaiboon M, Vatanasapt P. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. Cochrane Database Syst Rev 2008; :CD004975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/42\">",
"      Takata GS, Chan LS, Shekelle P, et al. Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics 2001; 108:239.",
"     </a>",
"    </li>",
"    <li>",
"     Amsden GW. Tables of Antimicrobial Agent Pharmacology. In: Principles and Practice of Infectious Diseases, 7th ed., Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2010. p.718.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/44\">",
"      Stenfeldt K, Hermansson A. Acute mastoiditis in southern Sweden: a study of occurrence and clinical course of acute mastoiditis before and after introduction of new treatment recommendations for AOM. Eur Arch Otorhinolaryngol 2010; 267:1855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/45\">",
"      Smith JA, Danner CJ. Complications of chronic otitis media and cholesteatoma. Otolaryngol Clin North Am 2006; 39:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/46\">",
"      Kong SK, Lee IW, Goh EK, Park SE. Acute otitis media-induced petrous apicitis presenting as the Gradenigo syndrome: successfully treated by ventilation tube insertion. Am J Otolaryngol 2011; 32:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/47\">",
"      Chole RA, Donald PJ. Petrous apicitis. Clinical considerations. Ann Otol Rhinol Laryngol 1983; 92:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/48\">",
"      Sadoghi M, Dabirmoghaddam P. Otitic hydrocephalus: case report and literature review. Am J Otolaryngol 2007; 28:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/49\">",
"      Lim ZM, Friedland PL, Boeddinghaus R, et al. Otitic meningitis, superior semicircular canal dehiscence, and encephalocele: a case series. Otol Neurotol 2012; 33:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/50\">",
"      Perera R, Haynes J, Glasziou P, Heneghan CJ. Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database Syst Rev 2006; :CD006285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/51\">",
"      Cantekin EI, Mandel EM, Bluestone CD, et al. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion (\"secretory\" otitis media) in children. Results of a double-blind, randomized trial. N Engl J Med 1983; 308:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/52\">",
"      Luxford WM, Sheehy JL. Myringotomy and ventilation tubes: a report of 1,568 ears. Laryngoscope 1982; 92:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/62/39913/abstract/53\">",
"      Xu YD, Ou YK, Zheng YQ, et al. The treatment for postirradiation otitis media with effusion: a study of three methods. Laryngoscope 2008; 118:2040.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6872 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-4F64B2DDF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39913=[""].join("\n");
var outline_f38_62_39913=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION OF OTITIS MEDIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Acute otitis media (AOM)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Otitis media with effusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute mastoiditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chronic otitis media",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EPIDEMIOLOGY OF AOM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ETIOLOGY OF AOM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3244861\">",
"      Eustachian tube dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Microbiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Bacteriology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Other organisms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Biofilms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Immunology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CLINICAL MANIFESTATIONS OF AOM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSIS OF AOM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40015059\">",
"      Bullous myringitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40015052\">",
"      DIFFERENTIAL DIAGNOSIS OF AOM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT OF AOM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Choice of initial antibiotic",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Penicillin allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Lack of initial response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Ruptured tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29565560\">",
"      COMPLICATIONS OF AOM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29565569\">",
"      Intratemporal complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14530790\">",
"      - Mastoiditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29565577\">",
"      - Facial paralysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29565584\">",
"      - Labyrinthitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29565591\">",
"      - Hearing loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29565598\">",
"      - Petrositis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29565607\">",
"      Extratemporal complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29565636\">",
"      - Epidural, subdural, and brain abscess",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29565646\">",
"      - Otitic hydrocephalus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29565654\">",
"      - Otitic meningitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29565663\">",
"      - Lateral sinus thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      OTITIS MEDIA WITH EFFUSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Treatment for OME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6872\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6872|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/32/33285\" title=\"figure 1\">",
"      Normal ear anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/5/41043\" title=\"figure 2\">",
"      Weber and Rinne tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6872|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?1/54/1891\" title=\"picture 1\">",
"      Acute otitis media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/53/39774\" title=\"picture 2\">",
"      Pneumatic otoscope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/14/5345\" title=\"picture 3\">",
"      Normal tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/6/20576\" title=\"picture 4\">",
"      TM air fluid level",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/26/12706\" title=\"picture 5\">",
"      Bullous myringitis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/49/19217\" title=\"picture 6\">",
"      Retracted tympanic membrane",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6872|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?24/11/24766\" title=\"movie 1\">",
"      otoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6872|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/32/7693\" title=\"table 1\">",
"      Predictive value TM exam",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/45/8925\" title=\"table 2\">",
"      Common drugs for external otitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/35/8760?source=related_link\">",
"      Acute otitis media in children: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/0/21514?source=related_link\">",
"      Acute otitis media in children: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1450?source=related_link\">",
"      Chronic otitis media, cholesteatoma, and mastoiditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=related_link\">",
"      Deep neck space infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17033?source=related_link\">",
"      Epidural abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/16/8458?source=related_link\">",
"      Eustachian tube dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/40/22153?source=related_link\">",
"      Otitis media with effusion (serous otitis media) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38104?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23145?source=related_link\">",
"      Septic dural sinus thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32438?source=related_link\">",
"      Treatment and prognosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13559?source=related_link\">",
"      Treatment of vertigo",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_62_39914="Prurigo nodularis 2";
var content_f38_62_39914=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F66268%7EDERM%2F53475%7EDERM%2F86816%7EDERM%2F86817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F66268%7EDERM%2F53475%7EDERM%2F86816%7EDERM%2F86817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prurigo nodularis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple nodules, some of which excoriated, on the lower limb of a patient with nodular prurigo.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prurigo nodularis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Discrete, excoriated nolules on the leg of a patient with nodular prurigo.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Prurigo nodularis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A prurigo nodularis nodule showing periferal hyperpigmentation and central scale.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Prurigo nodularis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39914=[""].join("\n");
var outline_f38_62_39914=null;
var title_f38_62_39915="Physio goals burn resus";
var content_f38_62_39915=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50423&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50423&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physiologic goals for fluid resuscitation for burn patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Mental status:",
"       </td>",
"       <td>",
"        Alert and comfortable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin:",
"       </td>",
"       <td>",
"        Warm and well-perfused",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Urine output:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &lt;30 kg, 1 to 2 mL/kg per hour",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\">",
"        &ge;30 kg, 0.5 to 1 mL/kg per hour",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Heart rate: normal mean heart rate for age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Newborn to 3 months:",
"       </td>",
"       <td class=\"sublist_other\">",
"        140 beats per minute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3 months to 2 years:",
"       </td>",
"       <td class=\"sublist_other\">",
"        140 beats per minute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2 years to 10 years:",
"       </td>",
"       <td class=\"sublist_other\">",
"        80 beats per minute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &gt;10 years:",
"       </td>",
"       <td class=\"sublist_other\">",
"        75 beats per minute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Systolic blood pressure (SBP): normal range for children &gt;1 year of age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        [Median SBP = 90 mm Hg + (2 x age in years)]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\">",
"        [Lower limit of SBP = 70mm Hg + (2 x age in years)]",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39915=[""].join("\n");
var outline_f38_62_39915=null;
var title_f38_62_39916="Skin ulcers in travelers";
var content_f38_62_39916=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Skin ulcers in travelers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Comments",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Bacteria",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Anthrax",
"      </td>",
"      <td>",
"       Hemorrhagic ulcer with surrounding edema; eschar",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Chancroid",
"      </td>",
"      <td>",
"       Painful genital ulcer; single or multiple",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Diphtheria",
"      </td>",
"      <td>",
"       Shallow ulcer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Granuloma inguinale",
"      </td>",
"      <td>",
"       Painless genital ulcer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Leprosy",
"      </td>",
"      <td>",
"       Neuropathic ulcers",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lymphogranuloma venereum",
"      </td>",
"      <td>",
"       Late ulceration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Melioidosis",
"      </td>",
"      <td>",
"       Necrotic ulcer with local cellulitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Mycetoma",
"      </td>",
"      <td>",
"       Ulcers with sinus tracts",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\" colspan=\"2\" rowspan=\"1\">",
"       Mycobacteria",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       M. marinum",
"      </td>",
"      <td class=\"sublist_other\">",
"       Nodules may ulcerate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       M. tuberculosis",
"      </td>",
"      <td class=\"sublist_other\">",
"       Nodule ulcerates at site of primary inoculation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       M. ulcerans",
"      </td>",
"      <td class=\"sublist_other\">",
"       Deep ulcer with undermined edges (Buruli)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Plague",
"      </td>",
"      <td>",
"       Breakdown of bubo",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Pyoderma",
"      </td>",
"      <td>",
"       Crusted ulcer associated with staphylococci and streptococci",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Rickettsial infections",
"      </td>",
"      <td>",
"       Eschar at inoculation site for some rickettsiae; may be multiple",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Syphilis",
"      </td>",
"      <td>",
"       Painless ulcer with indurated edge",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tropical ulcer",
"      </td>",
"      <td>",
"       Painful ulcer, necrotic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tularemia",
"      </td>",
"      <td>",
"       Ulceroglandular; ulcer at site of inoculation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Yaws",
"      </td>",
"      <td>",
"       Papule ulcerates",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Protozoa",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Amebiasis",
"      </td>",
"      <td>",
"       Rapidly growing, painful necrotic ulcers",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Leishmaniasis",
"      </td>",
"      <td>",
"       Painless, rolled edge; chronic; single or multiple",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Other",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Brown recluse spider bite",
"      </td>",
"      <td>",
"       Painful, edema, erythema; necrotic eschar",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39916=[""].join("\n");
var outline_f38_62_39916=null;
var title_f38_62_39917="Cisplatin and etoposide for relapsed germ cell tumors";
var content_f38_62_39917=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F63222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F63222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cisplatin and etoposide for relapsed germ cell tumors",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle length: 21 days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cisplatin",
"        </strong>",
"       </td>",
"       <td>",
"        20 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV per day",
"       </td>",
"       <td>",
"        Dilute with 250 mL normal saline (NS) and administer over one hour. Do not administer with aluminum needles or intravenous sets.",
"       </td>",
"       <td>",
"        Days 1 through 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Etoposide",
"        </strong>",
"       </td>",
"       <td>",
"        100 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV per day",
"       </td>",
"       <td>",
"        Dilute with 500 mL NS (concentration less than 0.4 mg/mL) and administer over one hour.",
"       </td>",
"       <td>",
"        Days 1 through 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hydration:",
"        </strong>",
"        Induction of diuresis using intravenous NS minimizes the risk of cisplatin nephrotoxicity. At least 2000 mL of NS should be administered at a rate of 100 to 125 mL per hour throughout the five days of treatment and continued for at least two hours after the last dose of cisplatin. Refer to UpToDate topic on \"Cisplatin nephrotoxicity\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        HIGH (&gt;90 percent frequency of emesis). Aprepitant can be given orally (125 mg on day 1, 80 mg on days 2 and 3) with ondansetron, prochlorperazine, and dexamethasone daily. Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Bost cisplatin and etoposide are irritants. Cisplatin can cause significant tissue damage; avoid extravasation",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Primary prophylaxis with granulocyte colony stimulating factors is not indicated. Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        Treatment in the setting of baseline renal dysfunction (creatinine &gt;3.0 mg/dL or GFR &lt;50 mL/min) requires a balanced discussion of the goals of treatment and the risks of administering cisplatin",
"        <sup>",
"         [3]",
"        </sup>",
"        . Refer to UpToDate topics on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\" and \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Basic metabolic panel (creatinine and electrolytes) prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Liver function tests prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor vital signs during etoposide infusion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for neurotoxicity; monitor for hearing loss prior to each dose of cisplatin; audiometry as clinical indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        Each cycle should begin on schedule regardless of the degree of myelosuppression",
"        <sup>",
"         [1]",
"        </sup>",
"        . If febrile neutropenia or thrombocytopenic bleeding occurs, a dose reduction of 25 percent for etoposide should be used for subsequent cycles.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neurologic toxicity:",
"        </strong>",
"        Neuropathy usually is seen after cumulative doses of cisplatin beyond 400 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        , although there is marked interindividual variation. Patients with mild neuropathy can continue to receive full cisplatin doses. However, if the neuropathy interferes with function, the risk of potentially disabling neurotoxicity must be weighed against the benefit of continued treatment. Refer to UpToDate topic on \"Neurologic complications of platinum-based chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Renal toxicity:",
"        </strong>",
"        It is recommended that subsequent doses of cisplatin be withheld until the serum creatinine is less than 3.0 mg/dL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, dose should be recalculated.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; GFR: glomerular filtration rate; CBC: complete blood count.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Loehrer PJ, et al. J Clin Oncol 1995; 13:470.",
"      </li>",
"      <li>",
"       Platinol (cisplatin) injection, powder, lyophilized, for solution. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 20, 2011).",
"      </li>",
"      <li>",
"       Toposar (etoposide) injection. US FDA-approved package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed December 20, 2011).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39917=[""].join("\n");
var outline_f38_62_39917=null;
var title_f38_62_39918="Effector systems";
var content_f38_62_39918=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 478px\">",
"   <div class=\"ttl\">",
"    Second messenger systems associated with G proteins",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 458px; height: 307px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    G proteins initiate cellular changes by acting directly on processes (such as ion channels) or through second messengers, which then affect cell proteins to alter function.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael A Shetzline, MD, PhD and Rodger A Liddle, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39918=[""].join("\n");
var outline_f38_62_39918=null;
var title_f38_62_39919="Dome shaped hemorrhage";
var content_f38_62_39919=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69754&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69754&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dome-shaped retinal hemorrhage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 321px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dome-shaped retinal hemorrhages may break into the vitreous.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Brian Forbes, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_62_39919=[""].join("\n");
var outline_f38_62_39919=null;
